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ABSTRACT OF DISSERTATION 
 
 
EXPRESSION OF ZINC FINGERS AND HOMEOBOXES 2 (ZHX2) AND ZHX2 
TARGET GENES IN MULTIPLE TISSUES OF WILD-TYPE AND ZHX2 
KNOCKOUT MICE 
The Spear lab has had a long-standing interest in gene regulation in the liver during 
development and disease.  Several years ago, these studies identified a novel transcriptional 
regulator called Zinc fingers and homeoboxes 2 (Zhx2), which is a member of a small 
family that includes Zhx1 and Zhx3.  All Zhx proteins contain two amino-terminal C2-H2 
zinc fingers and four or five carboxy-terminal homeodomains.  Previous studies indicate 
that Zhx proteins can form homodimers and heterodimers with each other. 
Zhx2 regulates numerous hepatic genes, including alpha-fetoprotein (AFP) and 
H19. Genes controlling lipid and cholesterol homeostasis are also regulated by Zhx2.  More 
recently, our lab has found that a number of Cytochrome P450 (Cyp) genes and Major 
urinary protein (Mup) genes are also targets of Zhx2. The BALB/cJ mouse substrain 
contains a natural hypomorphic mutation in Zhx2, and the aforementioned targets are 
dysregulated in the livers of adult BALB/cJ mice.  Recently, our lab developed mice that 
contain a floxed allele of Zhx2.  By crossing these mice with transgenic mice that express 
the Cre recombinase in all tissues or in hepatocytes, we can knock-out Zhx2 expression in 
all tissues or solely in the liver, respectively.  
Much of the research in the Spear lab has focused on the role of Zhx2 in liver gene 
expression during development and several models of liver disease. However, we have 
found that Zhx2 is ubiquitously expressed in all adult mouse tissues. The first part of my 
 
 
project has utilized whole-body Zhx2 knock-out mice to investigate the role of Zhx2 in 
various tissues, including kidney, brain, small intestine, liver, salivary and lacrimal glands.  
These studies indicate that some, but not all, previously identified Zhx2 targets are also 
regulated by Zhx2 in non-liver tissues.  I have also carefully evaluated whether the absence 
of Zhx2 results in increased perinatal lethality and/or altered postnatal growth. These 
studies suggest that postnatal growth of male Zhx2 knock-out mice is delayed compared to 
wild-type Zhx2 littermates.   
My second project examined subcellular localization of Zhx proteins. To 
accomplish this, GFP-Zhx fusion proteins were expressed in transfected cells. Zhx1 and 
Zhx2 localized to the nucleus whereas transfected Zhx3-GFP proteins were found in both 
the nucleus and cytoplasm. Moreover, when Zhx3-GFP was co-transfected with Zhx2, 
Zhx3-GFP was found strictly in the nucleus. This data suggests that interactions between 
Zhx proteins could alter protein localization.  I employed bioinformatics tools to predict 
the 3D structures of Zhx1, Zhx2, and Zhx3 monomers, homodimers, and heterodimers. 
 
KEYWORDS: Zhx2, Gene regulation, Bioinformatics, Protein structure, Knock-out mice.                                                 
 
                                                                                               
                                                                                               
 
 
 
 
 
 
 
 
 
                                                                                                Minen Al-Kafajy 
                                                                                                Student’s Signature 
 
                                                                                                12/9/16 
                                                                                                 Date 
 
 
 
 
 
 
 
EXPRESSION OF ZINC FINGERS AND HOMEOBOXES 2 (ZHX2) AND ZHX2 
TARGET GENES IN MULTIPLE TISSUES OF WILD-TYPE AND ZHX2 
KNOCKOUT MICE 
By 
Minen Al-Kafajy 
 
 
 
 
 
 
                                                                                                 Dr. Brett T. Spear, Ph.D 
                                                                                                 Director of Dissertation 
 
                                                                                                 Dr. Ken Fields, Ph.D 
                                                                                                 Director of Graduate Studies   
 
                                                                                                 12/9/16 
                                                                                                  Date 
iii 
 
ACKNOWLEDGMENTS 
 I would like to thank my mentor Dr. Brett T. Spear, PhD for providing me with the 
opportunity to work in his lab, and guiding me during the course of my graduate career.  I 
am honored to have Dr. Martha Peterson, PhD, Dr. Michael Kilgore, PhD, Dr. Joe 
McGillis, PhD and Dr. Subbarao Bondada, PhD on my committee, with much of 
appreciation for their valuable inputs and insightful suggestions to improve my research.  I 
would like to thank Dr. Nancy Webb, PhD for her willingness to serve as an outside 
examiner. I am extremely grateful for Dr. Patricia Bond, PhD in the graduate school for 
the encouragement that she has provided throughout my study period. 
I would like to acknowledge the Higher Committee for Education Development 
(HCED) in Iraq for their financial support during my course work at the University of 
Kentucky, which would have not been possible without their assistantship. I am extremely 
grateful for the Microbiology department for providing me with an excellent education and 
training.  
 This work would not have been achieved without the support and encouragement 
from my mother Layla. Finally, I would like to thank my lovely children Ali and Jenna for 
their patience and encouragement during my PhD career.  
 
 
 
 
 
 
 
 
iv 
 
TABLE OF CONTENTS 
ACKNOWLEDGMENTS ................................................................................................. iii 
Table of Contents ..............................................................................................................  iv 
List of Tables ................................................................................................................... viii 
LIST OF FIGURE.............................................................................................................. ix 
CHAPTER1 Introduction ....................................................................................................1 
The Liver ..................................................................................................................1 
Alpha-Feto protein (AFP) ........................................................................................3 
H19 ...........................................................................................................................4 
Methionine adenosyltransferase(Mat) genes ...........................................................4 
Zinc finger and homeoboxes 2 (Zhx2) .....................................................................5 
Zhx1 .........................................................................................................................6 
Zhx3 .........................................................................................................................7 
Kidney ......................................................................................................................8 
Zhx2 role in cancer ..................................................................................................8 
Zhx2 role in cardiovascular disease .........................................................................9 
Zhx2 role in brain function ....................................................................................10 
Major urinary proteins (Mups) ...............................................................................11 
Salivary and lacrimal glands ..................................................................................13 
Small intestine ........................................................................................................14 
CHAPTER2: Material and Methods ..................................................................................16 
Mice .......................................................................................................................16 
v 
 
Generation of the whole body Zhx2 knock out mice (Zhx2ko) ..............................16 
Genotyping .............................................................................................................16 
Mice euthanizing and tissue collection ..................................................................17 
Tissue homogenization and RNA extraction .........................................................17 
cDNA synthesis .....................................................................................................18 
Real-Time qPCR (RT-qPCR) ................................................................................19 
Cloning ...................................................................................................................19 
Cell Culture ............................................................................................................23 
Cell fixation ...........................................................................................................26 
Prediction of the proteins 3 dimentional structures and binding sites ...................26 
Statistical analysis ..................................................................................................27 
CHAPTER 3: Expression of Zhx2 target genes in multiple adult tissues of Zhx2+ and 
Zhx2- mice  ........................................................................................................................29 
Introduction ...................................................................................................................29 
Results ...........................................................................................................................33 
AFP levels are increased in the adult liver of whole body Zhx2ko mice ................33 
Zhx1 is expressed in multiple organs of male and female Zhx2wt mice ................33 
Zhx2 is ubiquitously expressed in adult male and female Zhx2wt mice ................33 
Zhx3 is expressed in several organs of Zhx2wt mice .............................................34 
Mups are candidate Zhx2 targets in the liver .........................................................34 
vi 
 
Mups are upregulated in the SG of Zhx2ko male mice...........................................34 
MUPs are upregulated in the Zhx2ko female mice SG ...........................................35 
The absence or the presence of Zhx2 does not alter the gene expression of Zhx1, 
Zhx3 and H19 in the mice SGs ..............................................................................35 
A trend towards a negative correlation between Zhx2 and MUP1 expression in male 
lacrimal glands (LG) ..............................................................................................36 
Mups are not regulated by Zhx2 in the male liver .................................................36 
Mat1a mRNA levels are decreased in adult male Zhx2ko mouse liver ..................37 
Mup24 is positively regulated by Zhx2 in the adult female liver ..........................37 
Zhx2 is positively correlated with Mat1a and inversely with Shp, lipid metabolism 
genes, in the female mice livers .............................................................................38 
Analysis of candidate Zhx2 targets in the kidney ..................................................38 
Zhx2 control gene expression in the brain .............................................................38 
Expression of Zhx genes and Zhx2 target genes in small intestine .......................39 
Discussion ..............................................................................................................40 
CHAPTER 4: The effect of Zhx2 in postnatal mouse survival  ........................................71 
Introduction ...................................................................................................................71 
Results ...........................................................................................................................71 
Postnatal survival of male Zhx2ko mice is reduced ................................................71 
Weekly measurement indicated a comparable weight gain of Zhx2wt, Zhx2het and 
Zhx2ko mice cohorts which have been fed normal diet (ND) ................................71 
Discussion ..............................................................................................................72 
CHAPTER 5: Zinc finger and homeoboxes (Zhx (family members Zhx1, Zhx2 and Zhx3: 
subcellular localization and predicted structural models ...................................................78 
Introduction ...................................................................................................................78 
vii 
 
Bioinformatics ...............................................................................................................80 
Results ...........................................................................................................................81 
Investigate the possibility that Zhx proteins could influence each other localization ..82 
Zhx1-GFP localization is slightly altered when co-transfected with Zhx3-HA ...........82 
Zhx2-GFP localization is not altered by co-transfection with Zhx1-HA, Zhx2-HA or 
Zhx3-HA .......................................................................................................................83 
Zhx3-GFP localization was altered by co-transfection with Zhx2-HA, but not by Zhx1-
HA or Zhx3-HA ............................................................................................................83 
Bioinformatics prediction of mouse Zhx1, Zhx2 and Zhx3 tertiary structure as 
monomers, homodimers and heterodimers and identification of domains predicted to be 
involved in the binding .................................................................................................80 
Prediction of homodimer formation ..............................................................................84 
Heterodimer prediction .................................................................................................84 
Discussion .....................................................................................................................85 
CHAPTER 6: Conclusion and future direction ...............................................................100 
APPENDIX ......................................................................................................................107 
REFERENCES ................................................................................................................117 
VITA ................................................................................................................................126 
 
 
 
 
 
viii 
 
 
LIST OF TABLES 
Table 2. 1 Genotyping mice primer sequences ..................................................................28 
Table 2.2. Quantitative real time polymerase reaction (PCR) primer sequences ..............28 
Table 4.1 Mice survival at p60 ..........................................................................................75 
Table 5.1 Computer prediction of domains participate in forming Zhx homodimer or 
heterodimer ........................................................................................................................89  
 
 
 
 
 
 
 
 
 
 
 
 
ix 
 
 
LIST OF FIGURES 
Figure 3.1 Hepatic Zhx2 mRNA levels are reduced and AFP and H19 mRNA levels are 
increased in the livers of Zhx2ko mice ...............................................................................48   
Figure 3.2 Zhx1 is ubiquitously expressed in adults Zhx2
wt
 mice .....................................49  
Figure 3.3 The highest Zhx2 mRNA levels are found in in male kidney and female small 
intestine of adult Zhx2
wt
 mice ............................................................................................50 
Figure 3.4 Zhx3 mRNA is expressed at equal levels in male and female Zhx2
wt
 kidney and 
SI ........................................................................................................................................51 
Figure 3.5 Zhx2 and Zhx2 targets are properly regulated in BALB/c and BALB/cByJ mice
............................................................................................................................................52 
Figure 3.6 Expression of Mup genes are inversely correlated with Zhx2 expression in male 
SG ......................................................................................................................................53 
Figure 3.7 The Mup1 and Mup18 are regulated by Zhx2 in female SG ............................54 
Figure 3.8  The lack of SG sexual dimorphism of MUP1 and MUP18, MUP24 and MUP25 
expression ..........................................................................................................................55 
Figure 3.9  The absence of Zhx2 does not alter Zhx1, Zhx3 or H19 levels in male SG....56 
Figure 3.10 The absence of Zhx2 does not alter Zhx1, Zhx3 or H19 levels in female 
SG ......................................................................................................................................57 
Figure 3.11 Expression of Mups are not altered in the absence of Zhx2 in male LG .......58 
Figure 3.12 MUP1 is the most abundant Mup in LG whereas Mup18 is the most abundant 
Mup in SG, as determined by RT-qPCR ............................................................................59 
x 
 
Figure 3.13 Expression of several Mup genes is not altered in liver of male Zhx2ko 
mice ....................................................................................................................................60  
Figure 3.14 Mat1a levels decrease in adult liver of male Zhx2ko mice .............................61 
Figure 3.15 Mup24 mRNA levels are reduced in adult female liver in Zhx2
ko
 mice ........62 
Figure 3.16 Zhx2  regulates Mat1a in the female mice liver .............................................63 
Figure 3.17 Expression of Zhx2 and candidate Zhx2 target genes in the male kidney .....64 
Figure 3.18 A positive trend was observed between Zhx2 and Stat5b in the females’ kidney
............................................................................................................................................66 
Figure 3.19 Candidate Zhx2 target genes are not altered in adult male Zhx2ko brain .......67 
Figure 3.20 Candidate Zhx2 target genes are not altered in adult female Zhx2ko brain ....68 
Figure 3.21 Zhx2 target gene expression is not altered in adult male Zhx2ko small intestine
............................................................................................................................................69 
Figure 3.22 Zhx2 target gene expression is not altered in adult female Zhx2ko small 
intestine ..............................................................................................................................70 
Figure 4.1 Comparable weight gain rates were observed in Zhx2
wt
, Zhx2
het
 and Zhx2
ko
 
males and female mice cohorts ..........................................................................................77 
Figure 5.1 Nuclear localization of Zhx1-GFP, Zhx2-GFP, and cellular localization of Zhx3-
GFP have been observed in mouse primary hepatocytes ...................................................91 
Figure 5.2 Cellular localization of GFP in HEK-293 and HeLa cells ...............................92  
Figure 5.3 Zhx2-GFP and Zhx1-GFP was observed in the nuclei while Zhx3-GFP was seen 
in the entire cell of HEK-293 cells ....................................................................................93 
xi 
 
Figure 5.4 Zhx3-HA partially altered Zhx1-GFP localization ...........................................94 
Figure 5.5 Zhx2 nuclear localization was not altered by Zh1-HA, Zhx2-HA or Zhx3-
HA ......................................................................................................................................95 
Figure 5.6 Zhx3-GFP whole cell localization was dramatically altered by Zhx2-HA co-
transfection in HEK-293 cells ............................................................................................96 
Figure 5.7 3 Dimensional structure prediction of mouse full length Zhx1, Zhx2 and Zhx3 
proteins ...............................................................................................................................97 
Figure 5.8 Simulation of the predicted Zhx1, Zhx2 and Zhx3 homodimer .......................98 
Figure 5.9 Simulation of the predicted mouse Zhx1, Zhx2 and Zhx3 heterodimer ...........99 
 
1 
 
CHAPTER 1 
Introduction 
 Liver 
The liver is the largest internal organ in mammals and performs multiple activities, 
including numerous metabolic functions, energy and glycogen storage [1]. The liver 
synthesizes numerous serum transporter proteins, such as albumin and transthyretin, as 
well as clotting factors. Furthermore, the liver eliminates toxic compounds by 
detoxification (i.e., ammonia) or excretion via bile acids (i.e., bilirubin). Energy storage is 
one of many essential liver functions and is accomplished, in part, by hepatocytes that 
engulf, synthesize, esterify, oxidize and export fatty acids [2]. The fetal liver is the site of 
embryonic hematopoiesis [3]. The liver is the main site for the synthesis and storage of 
triglycerides, an important energy source and major component of cellular membranes. 
Triglycerides are only one type of lipid synthesized in the liver. Others include lipoproteins 
such as very low density lipoprotein (VLDL), low density lipoproteins (LDL) and high 
density lipoproteins (HDL), which transport phospholipids and cholesterol [2]. Although 
grouped together, each form has unique metabolic properties. Variation in normal VLDL, 
LDL and HDL serum levels are strongly correlated with cardiovascular disease (CVD) [4]. 
Due to the huge clinical impact of CVD, there is considerable interest in the regulation of 
hepatic genes that control lipid homeostasis. Numerous transcription factors, including 
Peroxisome proliferator activated receptors (PPARα, β, γ1, and γ2), sterol regulatory 
element binding protein-1c (SREBP-1c), hepatic nuclear factors (HNF-4α and γ), retinoid 
X receptor (RXRα), liver X receptor (LXRα) ultimately regulate liver lipid homeostasis 
[5]. 
The liver has a distinctive structure that allows it to carry out its functions.  
Hepatocytes, which carry out a majority of liver functions and comprise roughly 60% of 
liver cells and 90% of liver volume, are arranged in small repeating hexagonal structures 
termed lobules [6]. Each of the six corners of this lobule contains a portal triad, comprised 
of the hepatic artery, portal vein, and bile duct.  Oxygen- and nutrient-rich blood enters the 
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lobule via the hepatic artery and portal vein, respectively. The blood exists via the central 
vein, located at the center of the lobule. Trafficking of compounds occurs as the blood 
passes by hepatocytes [7]. An interesting aspect of liver biology requires this unique 
architecture. Certain liver functions take place in hepatocytes surrounding the portal triad 
(periportal hepatocytes) whereas other functions occur solely in hepatocytes surrounding 
the central vein (pericentral hepatocytes, a phenomenon termed zonal gene regulation or 
metabolic zonation. This separation of function allows the liver to carry out opposing 
metabolic activities. [1], [6], [8].  
Since the liver receives blood with nutrient and possibly microbes from the gut and 
is therefore continually exposed to pathogens, it is considered an important immunological 
organ. Besides mediating metabolism, hepatocytes can initiate liver immunological 
tolerance. Although naïve T-lymphocytes in non-lymphoid organs generally do not interact 
with resident cells, hepatocytes, with their cytoplasmic extensions, and liver sinusoidal 
endothelial cells (LSEC) can interact with resident and circulating naïve CD+8 T-cell 
filopodia [9]. Furthermore, in inflammatory conditions, mouse hepatocytes might function 
as antigen presenting cells (APCs) via MHC class II proteins to activate CD4+ T-cells [10]. 
Kupffer cells, another type of non-parenchymal cell, are resident liver macrophages that 
reside mainly in the sinusoid periportal regions of the liver [11].  Kupffer cells can prevent 
inflammation by inhibiting pathogen growth and eliminating excess dietary materials [12]. 
Furthermore, the liver contains a considerable number of resident natural killer (NK) cells, 
also known as pit cells, that sensitize and kill the tumor cells and thus serve as an innate 
immune monitoring mechanism in the liver [13].  
The adult liver is largely a quiescent organ with a very low level of cellular 
proliferation. However, one of the unique and marvelous liver features is the ability to 
rebuild itself after damage, a phenomenon termed liver regeneration. In situations of 
modest injury, it is thought that normally quiescent hepatocytes can proliferate to restore 
liver mass. Repeated or more severe injury leads to the activation of a small population of 
bipotent stem cells, termed oval cells, that reside in the canals of Hering surrounding the 
portal triad [14]. Oval cells can give rise to hepatocytes and bile duct epithelial cells and 
are critical for normal regeneration [15]. Moreover, liver stellate cells, which store vitamin 
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A [16], secrete growth factors and cytokines necessary for liver function [7]. Stellate cells, 
also called lipocytes or vitamin A storing cells [16], are non-parenchymal cells that 
comprise about 15% of liver cells and reside in the subendothelial space. Upon repeated 
injury and through stimulation with TGF-beta or other cytokines, stellate cells differentiate 
into activated collagen-producing fibroblasts and contribute significantly to liver fibrosis. 
Liver fibrosis as well as other chronic liver diseases are characterized by accumulated 
extracellular matrix protein. Progressive fibrosis can lead to liver cirrhosis, liver cancer, 
and liver failure. Due to the importance of liver disease in the United States, scientists are 
trying to develop effective anti-fibrotic drugs to treat liver disease [17].  
Some liver proteins must be synthesized at all times, whereas other proteins are 
required during specific developmental time points or in response to various stimuli. Since 
changes in proteins occur primarily at the transcriptional level, there is considerable interest 
in liver gene regulation. Genes encoding alpha-fetoprotein (AFP), and the long non-coding 
RNA H19 are highly active in the fetal liver but are silenced after birth, and provide an 
experimental system to investigate postnatal gene repression in the liver.  
Alpha-Fetoprotein (AFP) 
The AFP gene, which encodes a 65 kDa glycosylated serum transport protein, is a 
member of the albumin gene family that is located on chromosome (Chr) five or four in 
mice and humans, respectively [18]. This small gene family contains albumin (Alb), Alpha-
albumin (AFM), Vitamin D-binding protein (DBP) [19], and alpha-fetoprotein related gene 
(Arg) [20]. AFP, along with the other albumin family members, is expressed mainly in the 
liver although AFP is also expressed abundantly in the extraembryonic yolk sac [21]. AFP 
and Alb are expressed early in the fetal liver, whereas DBP is activated later in the fetal 
liver; AFM and Arg are activated after birth. AFP is the only albumin family member that 
turns off after birth since Alb continues to be highly expressed in the adult liver. [22, 23]. 
AFP assist in mammals fetal development [24]. AFP is the most abundantly expressed gene 
in the fetal liver but exhibits a dramatic (105-fold) decrease in expression after birth [18]. 
While normally off in the adult liver, the AFP gene is reactivated during liver regeneration 
and often in hepatocellular carcinoma (HCC). Since AFP can be readily detected in the 
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blood, its reactivation during HCC makes AFP an important cancer marker [25]. Moreover, 
AFP has been used as gestational marker during pregnancy as elevated maternal AFP levels 
may indicated neural tube defects in the developing fetus [26]. Furthermore, maternal 
serum AFP can be used as a test for Downs syndrome through the first trimester of 
pregnancy [27]. The mechanisms that govern changes in AFP expression during 
development and disease are not fully understood. 
H19 
The H19 gene is located on Chr 7 and Chr 11 in mice and humans, respectively. 
H19 is among the first long non-coding RNA (lncRNA) to be discovered; these classes of 
RNAs are transcribed by RNA polymerase II and polyadenylated but do not encode a 
protein and therefore function as a noncoding RNA.  Another unique feature of H19 is that 
it is imprinted, i.e., an autosomal gene that is expressed solely from the maternal- or 
paternal-derived chromosome. In the case of H19, only the maternal H19 allele is 
expressed. H19 is expressed abundantly in multiple fetal tissues such as liver, heart, 
skeletal muscles and gut. H19 is repressed after birth in the liver [28, 29] and kidney [30] 
but continues to be expressed in the adult skeletal muscle and the heart. H19 encodes for 
the micro-RNAs miR-675 3p and miR-675 5p, both of which play a role in skeletal muscle 
differentiation and regeneration [31]. 
H19 expression is localized in the fetal ureteric bud branches and epithelial 
elements of kidney metanephros. Pregnant mice exposed to a high glucose diabetogenic 
diet leads to decreased fetal kidney H19 expression [30]. Furthermore, H19 is 
hypermethylated and silenced in kidneys of Wilm’s tumor protein and frequently activated 
in HCC [29]. These data suggest that H19 might play role in normal liver and kidney 
function. 
 Methionine adenosyltransferase (Mat) genes 
Mat2a is a member of Mat gene family that also includes Mat1a. Mat2a gene is 
expressed in the fetal liver, but is gradually silenced after birth and replaced by the related 
Mat1a, which is expressed in the mature liver. The Mat genes have been a point of scientific 
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interest after Kinsell et al in 1947 noticed that liver cirrhosis patients have lower 
methionine metabolism [32], [33]. 
Adults human and mouse Mat1a, in the liver, encodes for the methionine adenosyl 
transferase enzymes MATI and MATIII, while Mat2a, in the kidney, code for MatII [34] 
[35]. MATI, II and III control cellular levels of S-adenosyl methionine (SAMe, also called 
AdoMet), derived from methionine. Since SAMe is the sole methyl donor for DNA 
methylation, these MAT enzymes are important in epigenetic gene regulation.  Mat1a can 
function as a source of propylamine that is important in polyamine biosynthesis [33], [34].  
MATI, MATIII and SAMe levels are reduced in non-alcoholic fatty liver disease 
(NAFLD). Mat1a knock out mice exhibit altered lipid homeostasis due to the severe 
reduction in MATI, MATIII and SAMe levels [36]. A second group independently reported 
that Mat1a knock out mice are more prone to develop fatty liver at twelve weeks old and 
had suffered oxidative stress and liver steatosis at two years of age [33]. Moreover, Mat1a 
knockout mouse developed liver tumors after treatment with the hepatotoxin carbon 
tetrachloride (CCl4) [37]. The importance of Mat1a is not limited to the hepatic tissue, 
SAMe is found in the kidney, brain and skeletal muscles [38]. Additionally, SAMe levels 
are dramatically reduced in HepG2 and Huh7 human hepatoma cell lines and human HCC 
[35]. Worth notable that Mat2a is expressed in the fetal liver, switch off after birth, and 
reactivated in liver regeneration and HCC [39]. 
Zinc fingers and homeoboxes 2 (Zhx2) 
As mentioned previously, AFP is expressed in the fetal liver and silenced at birth. 
Consistent with this, serum AFP levels also decrease dramatically within the first month 
after birth. However, serum AFP levels in adult BALB/cJ mice are 5-20 fold higher than 
other mice strains, including the closely related BALB/cBOM and BALB/cBy substrains 
[40]. Further studies indicated that this was an autosomal recessive trait governed by a 
locus on mouse Chromosome 15 that was called Alpha-fetoprotein regulator 1 (Afr1) [41]. 
Adult liver AFP mRNA levels are also elevated in BALB/cJ mice, suggesting that this 
increase was due to a change in gene expression. In addition, the H19 and Glypican 3 
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(Gpc3) genes also appear to be targets of Afr1 since they are also expressed in the fetal 
liver, silenced at birth, and elevated in adult liver of BALB/cJ mice [42]. Interestingly, 
AFP, H19 and Gpc3 are frequently activated in HCC. 
Using a positional cloning strategy, the Spear and Peterson labs identified Zhx2 as 
the gene responsible for the Afr1 phenotype. The Zhx2 gene in BALB/cJ mice contains a 
natural hypomorphic mutation induced by the insertion of an endogenous retroviral 
element into the first Zhx2 intron that dramatically reduces, but does not eliminate, Zhx2 
expression. Expression of a Zhx2 transgene in the livers of BALB/cJ mice restored normal 
postnatal silencing of AFP, H19 and Gpc3, confirming that the Zhx2 mutation was 
responsible for continued expression of these genes in adult BALB/cJ liver [43]. 
The Zhx2 gene contains four exons with the entire protein coding region found in 
exon 3. The mouse and human Zhx2 proteins are 836 and 837amino acids in length, 
respectively and are 87% identical [44]. Zhx2 has two amino-terminal C2-H2 zinc fingers 
(ZFs) and four carboxy-terminal homeodomains (HDs) [6]. The ZFs may be involved in 
nucleic acid binding or protein-protein interactions whereas the HDs likely function as 
DNA binding sites [45]. It has been hypothesized that Zhx2 functions as a transcriptional 
repressor [46] [47]. However, recent studies suggest that Zhx2 positively regulates 
elongation of very long chain fatty acids like 3 (Elovl3) [48] and Major urinary proteins 
(MUPs) in the liver [Chapter 3 and Spear unpublished data].  
Zhx2 belongs to a small gene family that also includes Zhx1 and Zhx3, although Zhx2 has 
a predicted proline-rich region adjacent to HD2,which is hypothesized to be involved in 
DNA binding [6].   
Zhx1 
The Zhx1 and Zhx2 genes are closely linked on mouse Chr 15 and human Chr 8, 
which raises the possibility that a genetic duplication created both genes. Zhx1 was 
identified for the first time in 1996 by immunoscreening of a bone marrow stromal cell 
line. Zhx2 consists of 873 amino acids [49]. Moreover, Zhx1 has been detected in a yeast 
2-hybrid search for proteins that have a potential to bind the activation domain A subunit 
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of NF-YA [46, 50]. NF-YA is an ubiquitous transcription factor that bind to specific genes 
promoters and activate their transcription [51]. Zhx1 has two C2H2 zinc fingers on the 
amino-terminal end and five homeodomains (HD)s on the carboxy-terminal end. Northern 
blot analysis indicates that Zhx1 is ubiquitously expressed with highest expression in the 
brain, moderate expression in the testis, kidney, and liver and very low expression in the 
skeletal muscle and heart [49]. It has been reported that ZHX1 functions as a transcriptional 
repressor [52], and ZHX1 and NF-YA are thought to govern transcription of genes critical 
for cell growth and differentiation [46].  
Zhx3 
Zhx2 and Zhx1 are proposed to heterodimerize in the cytoplasm with Zhx3, another 
member of Zinc finger and homeodomain family. Zhx3 is located on human chromosome 
20 and mouse chromosome 2. Zhx3 was discovered in a yeast 2-hybrid screen for Zhx1-
interacting proteins. Zhx3 is ubiquitously expressed and codes for a 956 amino acid protein 
that can homodimerize or heterodimerize with NF-YA [47]. Human ZHX3 is a predicted 
104.7 kDa protein with a 5.68 PI [47]. 
It has been hypothesized that Zhx3 functions as an important regulator in 
podocytes. Translocation of Zhx3 from the cytoplasm to the nucleus has been observed in 
rat and human podocytes and correlates with expression of the Wilms tumor (WT) gene 
that is crucial for normal kidney function and a marker for kidney tumor and focal sclerosis 
disease. Downregulating ZHX3 correlates with WT1 downregulation and increased levels 
of nuclear ZHX1 and ZHX2 in the kidney [53].  
Northern blot of various tissues has revealed that human ZHX3 is highly expressed 
in the testis and kidney. It is also expressed moderately in the skeletal muscles and at low 
but detectable levels in the heart, brain, placenta, lung, liver, pancreas, spleen, thymus, 
prostate, ovary, small intestine, colon and nearly negligible level in the leucocytes [47].  
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Kidney 
The kidney is a glandular organ consisting of sieves to purify the urine. The kidney 
keeps the body hydrated by controlling electrolytes, water, sodium, renin, and vasoactive 
eicosanoids. The kidney carries out several metabolic functions and helps maintain blood 
pressure [54] via filtrating and reabsorbing molecules [55]. The kidney consists of 
hundreds of thousands of structural unites termed nephrons. Every nephron unit consists 
of one glomerulus which is a sieve structure with pores allowing molecules with a 
molecular mass <50 kDa to be excreted to the urine and the highest mass molecules 
reabsorbed back to the plasma [56].  
Zhx2 role in cancer  
One million individuals are diagnosed with HCC every year worldwide [57]. HCC 
is characterized by poor prognosis in its advanced stages and is the third most fatal and the 
fifth most widespread cancer [58]. HCC early-stage diagnosed patients are usually treated 
by liver resection or transplantation. Unfortunately, HCC is usually diagnosed at the 
advanced stages; subsequently, the only treatment option left is using chemotherapy such 
as doxorubicin and cisplatin. Regrettably, advanced HCC stages are highly resistant to 
these drugs [59]. HCC is induced by a number of altered genetic and epigenetics pathways 
including p53, PTEN, PI3K, AKT, mTOR, Ras, Raf, MAPK and miRNAs [60-62]. 
Moreover, the palindromic group GPC (5’-CG-3’) ZHX2 promoter have been observed to 
be hypermethylated in HCC tumor as compared to neighboring non-tumor region and 
HepG2 cell line using methylation sensitive restriction finger printing (MSRF) [63]. This 
suggests that methylation-dependent silencing of Zhx2 is associated with HCC.   
Even though the roles of Zhx2 in hepatocellular carcinoma (HCC) have not been 
well addressed yet, preliminary data, along with previous publication, have shown ZHX2 
as a potent regulator of HCC proliferation in vitro and in vivo by inhibiting hexokinase II, 
cdc25C and AFP [43, 46, 64]. ZHX2 transcriptional repressor activity has been 
hypothesized to be linked to the presence of a proline-rich region in HD1 and a 
dimerization domain located between amino acids 263 and 446 [46]. Zhx2 reduces HCC 
cell proliferation and growth of xenograft tumors in nude mice by downregulating Cyclins 
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A and E expression. Knocking down ZHX2 in the SMMC7721 cell line has shown an 
increased cell proliferation rate. However, knocking down Cyclin A and E was partially 
able to reduce the proliferation, suggesting that ZHX2 might positively regulate tumor 
suppressor genes or negatively regulate oncogenes [65]. 
Zhx2 in cardiovascular disease 
BALB/cJ mice exhibit a cardioprotective trait called Hyplip2, which is 
characterized by low cholesterol and lipoprotein levels and small plaque lesion size when 
placed on a high fat diet as compared to the other mouse strains. Transgenic studies 
performed by Dr. Jake Lusis in collaboration with our lab have identified Zhx2 as the gene 
responsible for the Hyplip-2 trait [66]. In addition, BALB/cJ mice have high tendency to 
have increased fatty liver and liver damage when placed on a high fat diet. This study 
indicates that Zhx2 is essential for liver lipid trafficking [Clinkenbeard Thesis, 2011].  
Cardiovascular disease (CVD) and non-alcoholic fatty liver disease (NAFLD) are 
rising complications in the United States and western countries [67]. NAFLD is a metabolic 
disorder characterized by the accumulation of lipoprotein triglycerols (TAGs) in 
hepatocytes. Long-term consequences of NAFLD include advance staged steatohepatitis, 
cirrhosis and in rare cases can lead to hepatocellular carcinoma [68]. The primary cause of 
mortality in patients is when NAFLD progresses to non-alcoholic steatohepatitis (NASH) 
and ultimately to HCC, even in the absence of cirrhosis if NASH patient has insulin 
resistance [69]. Notably, insulin-resistant adipocytes will release more fatty acids into the 
circulation and eventually will cause CVD [70]. Numerous genes have been examined for 
their link to atherosclerosis in GWAS study, one of those genes located on chromosome 
8q24 was proposed to be related to carotid intima media thickness. This genetic locus is 
occupied by Zhx2 [67]. A second independent GWAS study also identified Zhx2 as a 
candidate of carotid intima media thickness and plaque (CIMT) marker in Caucasians [71]. 
Unfortunately, the mechanism by which Zhx2 correlates with CIMT has not been 
characterized, but the relationship with lipid homeostasis is intriguing. 
 Earlier studies and data from our lab indicate that Zhx2 is important for lipid 
homeostasis and regulates critical metabolic genes [72] [Creasy Thesis, 2015]. Zhx2 
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upregulates Elovl3 and represses Lipoprotein lipase (Lpl), which control liver lipid 
metabolism [48]. Liver-specific Zhx2 knock out mice (Zhx2Δhep) have elevated Lpl and 
decreased Elovl3 compared to wild type mice. Unexpectedly, this study did not detect 
differences in weight gain between Zhx2Δhep and Zhx2wt mice [Creasy Thesis, 2015]. In 
conclusion, there is a correlation between Zhx2, cardiovascular disease, liver disease, and 
lipid homeostasis. 
Zhx2 role in normal brain function 
The brain consists of a complex of neuronal and non-neuronal support cells that 
carry on delicate and unique functions such as feeling, intelligence, memory and social 
behavior. The mouse brain is comprised of seven main parts, including the olfactory bulb, 
cerebral cortex, hippocampus, midbrain, cerebellum, medulla and hypothalamus [73]. The 
mouse brain has an amazing and complex gene expression pattern that enables regions of 
the brain to interact and carry out its numerous functions [74]. 
Zhx2 has been reported to contribute to neural progenitor differentiation in the 
developing cerebral cortex via binding to the cytoplasmic domain of Ephrin-B. Ephrin-B, 
a member of type I transmembrane proteins family that includes B1, B2 and B3 which bind 
to the tyrosine kinase of ephrin B receptor (EphB) [75]. Zhx2 is expressed in the ventricular 
(VZ) and subventricular (SVZ) zone of the mouse cortex where neuronal progenitor cells 
reside. Ephrin-B is localized within the same location in the cortex with Zhx2. 
Overexpression of Zhx2 in vitro cultured cortical neural progenitors caused reduction in 
the number of neuronal and basal progenitor cells [76]. Taken together, these data suggest 
that Zhx2 functions as a repressor of neuronal differentiation in the cortex. 
DNA sequence analysis of Native American and British patients suffering from 
asymmetric Parkinson disease, revealed mutations in ZHX2 along with other genes 
regulated by miR-4277 [77]. Moreover, ZHX2 is upregulated in the dorsal root ganglia 
(DRG) of rat after intraplantar complete Freunds’ adjuvant (CFA) treatment [78]. GWAS 
studies for Autism Spectrum Disorder (ASD) patients has shown an association with 
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inherited copy number variation (CNV) of the ZHX2 locus [79]. Taken together these data 
provide further evidence that Zhx2 might be required for normal brain function. 
Major urinary proteins (Mups) 
Psychiatric disorder studies have utilized BALB/cJ mice as an experimental model 
system, since they exhibit behavioral anomalies compared to C57BL/6J mice [80]. For 
example, BALB/cJ mice have a small brain size [81]. Moreover, BALB/cJ male mice are 
more aggressive than BALB/c and its substrains, including BALB/cH and BALB/cBYJ. 
BALB/cJ mice have decreased level of urinary Mup proteins compared to the closely 
related BALB/cBy strain [82]; studies from our laboratory indicate that this is due to the 
natural Zhx2 mutation in BALB/cJ mice. Quantitative trait locus mapping identified three 
loci that control aggressive behavior in BALB/cJ male mice, including one that maps near 
the D15Mit46 microsatellite that resides close to Zhx2 gene [83]. These data raise the 
possibility that Zhx2, possibly through its control or Mup expression, might have a role in 
mice social behavior. 
Mups belong to a gene family comprised of roughly 20 genes and 20 pseudogenes 
that are highly related and tightly linked on mouse chromosome 4.  Mups are expressed at 
low levels at birth, but their expression increased gradually and reaches a stable level 
several months after birth [84] [Jiang et al, submitted]. Mup proteins are acidic with low 
molecular weight (20 kDa) and are structurally similar [85]. The liver is the major site of 
Mup synthesis; Mups are the most abundantly expressed genes in the adult mouse liver and 
comprise 5-10 % and 1-2% of total mRNA in male and female liver, respectively [86]. 
Mups circulate in the blood to be secreted via the kidney to the urine, where they are the 
most abundant proteins [87]. Male rat liver, but not female liver, expresses α2µ-globulin 
as the rat version of major urinary protein via 20 closely related genes and also excreted to 
the urine [88]. 
Mups are hypothesized to possess two functions. Mups are members of the lipocalin 
family and as such have been proposed to function as pheromones (odorants) transporters. 
Pheromones are compounds produced by one animal and target to other animals as a way 
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to communicate. The lipocalin protein tertiary structure includes eight beta sheets 
organized in a β-barrel with one open end. Both the amino (N) and the carboxy (C) terminal 
ends have α-helices [89], which give Mups a hydrophobic pocket (glove) that enables Mups 
to bind pheromone ligands [90]. The pheromones will be sensed by neurons located in the 
vomeronasal organ (VNO) and main olfactory epithelium (MOE), the chemosensory 
structures of the nasal cavity, so the animal can smell and communicate with other 
members of the same species. Lipocalins can bind pheromones and stabilize their scent in 
nature [91]. The second proposed function of MUPs are to act as pheromones themselves 
[92]. 
Group I Mups (old name of liver Mups) were reported to be produced in the liver 
and their mRNAs levels are 30% higher in lean mice as compared to the obese (ob/ob) 
mice. The ob/ob mice RNA level can be partially increased if the animal is treated with 
rosiglitazone, an antidiabetic drug that target insulin sensors. On the other hand, circulating 
group I Mups are reduced in genetically diabetic obese mice. In conclusion, animal 
nutrition influences Mup RNAs and proteins levels [93].  
Steroid hormones also play a role in determining Mup RNA and protein levels. 
Mups are sexually dimorphic in the liver as males express more MUPs than females. 
Lacrimal glands (LG), another site of Mup expression, are similar to the liver in that males 
express Mups at higher levels than females. One percent of lacrimal gland mRNAs are 
Mups [94]. Although, Mups are sexually dimorphic in the liver and lacrimal glands, there 
is no sexual dimorphism in the submaxillary, sublingual, and parotid gland (salivary 
glands; SG) between male and female. Female Mups are responsive to hormonal 
regulation; treating females with testosterone or thyroxin or growth factor will elevate Mup 
RNA and protein levels to almost equal to males, although this response is not observed in 
hypophysectomized female mice, indicating the importance of the pituitary gland in sexual 
dimorphic Mup expression [95]. The transfer of castrated male mice as intruders to a cage 
of different male mice will not initiate a fight, as the intruder will not excrete 
aggressiveness pheromones [92]. Little mice have a natural mutation in their growth 
hormone (GH) gene that leads to dwarfism and other developmental delays. Interestingly, 
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little mice have low Mup levels which can be restored by GH treatment [96]. These findings 
demonstrate the importance of hormones in regulating MUPs. 
One challenge in studying Mups is the irregular terminology that has been used by 
different groups. For example MUPI, MUPII, MUPIII are terms used to describe liver 
MUPs, while MUPIV and MUPV are referred to MUPs that have been synthesized in the 
lacrimal and submaxillary gland, respectively [97]. On the other hand, isolated urinary 
Mups were initially called MUP1, 2 & 3 [98] [85]. The new nomenclature is based on 
cloning of Mup genes of C57BL/6J mice that can be separated into two classes. Class A 
Mups include Mup1, Mup2, Mup18, Mup24, Mup25, Mup26 and 5 Class A pseudogenes. 
Class B Mups (refered to as MupU in this dissertation) consist of Mups 3-17 and are >97% 
identical and also include a number of pseudogenes. Mups 3, 8, 17, 24 and 25 are expressed 
in the liver, while MUPs 1, 3, 18, 24 and 26 are expressed in the submaxillary glands. 
Mup1 and Mup18 are also called MUPIV and MUPV, respectively [99]. 
Although functional Mup genes are not present in human, menstrual synchrony is 
an example of a pheromone-induced involuntary change in women. Specific compounds 
resembling pheromones, synthesized by female axillary glands, can enhance the production 
of luteinizing hormone of the recipient women and change their cycle time. Similar 
observation have also been detected in females rats [100]. Humans have chemoreceptive 
structures containing bipolar neurons that resemble VNO in mice, located in the base of 
nasal cavity to sense pheromones [101]. Curiously, Mups prompt female mouse ovulation 
through triggering nerves in the VNO [102]. For these reasons, our lab has an interest in 
studying the expression and function of Mups. 
Salivary and lacrimal glands  
The salivary glands (SG), which are exocrine glands, are a crucial organ in oral 
health that synthesize saliva, mucous and serous [103]. Saliva performs numerous 
functions such as buffering and neutralizing mouth bacterial acid, lubricating, 
supplementing teeth with essential mineral since it contains calcium, phosphate and 
proteins. Impairment in saliva production (hyposalivation) can cause dental disease and 
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mouth mucosal membrane abnormalities [104]. Salivary gland malfunctions can be 
induced by Sjogren’s Syndrome, certain medications, salivary gland tumors, stones that 
block the SG ductal system or radiotherapy [103, 105, 106]. Rodents (mice and rats) 
resemble human salivary glands by comprising of three ocular pairs termed parotid, 
submandibular and sublingual glands, the last two of which are blanketed by a common 
fascia and separated by connective tissue. Although, human parotid glands are similar to 
mice in having pure serous acini (singular acinus) bordered by myoepithelial cells, they are 
different in that humans have adipocytes that are absent in mice. Submandibular glands are 
composed of serous and mucous acinar cells in human and only serous cells in mice. 
Sublingual glands are unique in structure by having mucous cells in the middle surrounded 
by serous cells [103]. Rodent salivary glands secret saliva into the glandular bodies at the 
bottom of the oral cavity via excretory channel lining by ductal cells, which are the 
predominant salivary glands cells along with the acinar cells. Acinar cells synthesize 
proteins and primary saliva [107].  
In contrast, lacrimal glands (LGs) are binary almond-shaped glands that secret tears 
to the cornea to facilitate vision. LGs distorted by age or disease such as Sjogrens’ 
syndrome, an autoimmune disease, can lead to dry-eye disease (DED) [108]. Dartt 1989 
has stated that LGs mainly consist of secretory acinar cells which compromised 80% of the 
total forming cells, however, LGs also contain ductal and myoepithelial cells. LGs defend 
the eye via producing the antibacterial substances such as lysozyme and lactoferrin. 
Moreover, LGs maintain eye health by synthesizing and excreting growth factor α (GF α) 
[109]. Stimulation of LG secretion can be initiated by eye afferent sensory nerves and 
growth factors [110]. 
Small intestine  
Duodenum, jejunum and ileum are grouped in the term small intestine, while 
caecum, colon and rectum comprise the large intestine. Both form a tube covered by a 
single columnar epithelium layer. The small intestine (SI), along with the large intestine 
and the stomach form the gastrointestinal tract that mainly digests and absorbs nutrition. 
The small intestine is unique within the gastrointestinal tract by exclusively having villi. 
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Villi are finger-like extensions located on the inner side of the small intestine and are 
crucial for food digestion and absorption. The small intestine is comprised of three layers 
organized from the inside cavity to the outside termed the mucosa, propria and muscularis 
mucosa. The main cells in the small intestine are neuroendocrine cells, Paneth cells, goblet 
cells, dendritic cells, eosinophil and the adsorptive enterocytes [111]. Crohn’s disease and 
ulcerative colitis are two well-known types of small intestine disease [112].  
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CHAPTER 2 
Materials and Methods: 
Mice: 
Following our lab approved protocol of the Institutional Animal Care and Use 
Committee (IACUC), mice were maintained in the Division of Laboratory Animal 
Research facility (DLAR), and kept in micro-isolator cages. The mice were provided with 
food and water ad libitum and were on a 14-10 hr light-dark cycle. 
Generation of whole body Zhx2 knock out mice (Zhx2ko): 
The KnockOut Mouse Project (KOMP) at the University of California at Davis 
generated C57Bl/6 mice having Zhx2 exon 3 floxed with loxP site. Exon 3 is the only 
protein-coding exon of the Zhx2 gene. These mice were maintained on a C57BL/6 
background. Floxed mice were bred to Actin-cre transgenic mice (E2α-cre, Jackson 
Laboratory # 003724) to obtain mice which had deleted Zhx2 in all cells, including germ 
cells. Mice with the deleted Zhx2 exon 3 (Zhx2-) were bred to mice with wild-type Zhx2 
(Zhx2+) to obtain Zhx2+/- offspring. F1 intercrosses were performed to obtain Zhx2+/+ 
(referred to as Zhx2wt), Zhx2+/- (Zhx2het) and Zhx2-/- (Zhx2ko).   
Genotyping: 
1. Each mouse pup, around 13-days old was given an ear tag for identification; the ear 
punch, along with approximately 1mm tail snip cut were placed in 1.5 ml Eppendorf 
tube.  
2. Genotyping was accomplished by quick DNA extraction assay as described by 
Jackson lab (www.jax.org) with a few modifications. 
3. 100 µl of 50 mM NaOH was added to ear punch and the tail piece. 
4. The mixture was heated at 95 ºC for 10 min in dry bath. 
5. 25 µl of 50mM Tris-HCL pH 5.5 was added to the tubes. 
6. The remaining material was pelleted via centrifugation at 12,000 RPM for 5 min. 
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7. Four µl of the DNA (supernatant) was mixed with 6 µl of the primers (table 2.1) 
and 10 µl of 2x my tag red mix (bioline # 25043). 
8. The mixture was placed in semi-quantitative RT-PCR thermocycler machine and 
underwent the following protocol: 1 cycle of initial denaturation at 95ºC for 1 min, 
followed by 35 cycles of denaturation at 95 ºC for 15s, annealing 52 ºC for 15s, and 
extension at 72 ºC for 10s.  
9. In 0.5 ml tube, 10 µl of the PCR product was mixed with 3 µl of 6x loading dye 
(Fermentas). 
10. The mixture was vortexed and separated on 1% w/v agarose (SeaKem) gel, along 
with 100 bp ladder. The bands were visualized by UV light and the picture was 
captured using images software. 
 
Mice euthanizing and tissue collection: 
150 mice (males and females) were retained on normal diet for 60 days with weekly 
weight measurements. On day 60, 25 males (6 Zhx2wt, 13 Zhx2het, 6 Zhx2ko) and 24 females 
(7 Zhx2wt, 10 Zhx2het, 7 Zhx2ko) were food-fasted for 5hrs (9:00 am-2:00 pm); however, 
they had access to water. Mice were euthanized using CO2 and dissected to collect liver, 
kidney, small intestine, brain, salivary gland, lacrimal glands and spleen. The tissues were 
quickly frozen in dry ice and stored at -80 ºC for subsequent RNA isolation. The left side 
of the brain was placed in OCT media, quickly frozen in liquid nitrogen and kept at -80 ºC 
for future immunohistochemistry staining. 
Tissue homogenization and RNA extraction:  
Principle: 
RNAzol contains phenol and guanidine that bind with high affinity to DNA, proteins, 
polysaccharides, facilitating the isolation of RNA of high purity.  
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Procedures:  
1. Frozen mice tissues were obtained from -80 ºC freezer and placed in dry ice to 
avoid tissue thawing during the homogenization.  
2. RNA was extracted using 1ml of cold RNAzol (Molecular research center # 
RN190), that was added to approximately 50 mg of the tissue kept in 1.5 micro 
centrifuge tubes.  
3. The tissue was homogenized manually on ice using plastic douncer for (5-15 min) 
depending on the tissue type. The plastic douncer was cleaned and autoclaved after 
each sample. 
4. Since the brain has more fat than other tissue, preparing high quality brain RNA 
was difficult. To overcome this problem, brain homogenate was placed in dry ice 
to freeze the fats into a white-yellowish layer on the tube sides. Quickly, the 
aliquots were transferred to different tubes to remove fats.  
5. 0.4 ml of sterile ddH2O was added to the samples, each tube was mixed vigorously 
by hand for 30 seconds, vortexed, then all the samples were stored for 15 min at 
4ºC.  
6. The samples were spun down at 12,000 RPM in microcentrifuge tubes for 15 mins. 
Approximately 1ml of supernatant was added to 1ml isopropanol, mixed together, 
vortexed and stored at 4ºC for 15-30 mins.  
7. Following centrifugation as before, the supernatant was decanted and the RNA 
pellets were washed twice with 95% ethanol. Pellets were slightly air dried for no 
more than 10 mins to avoid over drying and resuspended in 30-50 μl of DNAase/ 
RNAase free sterile ddH2O proportional to the pellet size.  
8. The RNA purity and concentration were determined using spectrophotometer 
(Nanodrop) at 260 nm. A260/280 ratio was around 2 was used to confirm the purity 
of RNA samples. 
cDNA synthesis: 
Principle: 
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Reverse transcriptase via random primer scheme will generate cDNAs from the RNA 
template.  
Procedure: 
1. 10x RT buffer, 25x dNTP (100mM), 10xRT random primers, Multiscribe TM 
reverse transcriptase, RNase inhibitor and nuclease free H2O were added in this 
order to the individual thermal tubes. All these reagents were provided by the high 
capacity cDNA reverse transcription kit purchased from Thermofisher scientific (# 
4368813). 
2. 1µg of RNA was added to the thermal tubes and reverse transcribed into 20 µl of 
cDNAs after placed in the thermal cycler (PCR) at 25 ºC for 10 min, 37 ºC for 120 
min, 85 ºC for 5 min, then hold at 4 ºC until being transferred to -20 ºC fridge for 
long term storage.  
Real-Time qPCR (RT-qPCR) 
Gene sequences were obtained from Ensemble (useast.ensemble.org) or the NCBI 
website and entered into Primer Quest Tool (Integrated DNA technologies; IDT) to blast 
and design primers and predict the perfect melting temperature. Caution was taken in 
designing primers to rule out homology to other genes. 1µl of cDNA was amplified via 
RT-qPCR (Bio-Rad; Hercules, CA) following the manufacturer’s protocol after being 
mixed with 2x SYBR green PCR supermix (Bio-Rad # 720001784) and appropriate 
primers (Table 2.2).  The ribosomal L30 protein mRNA (L30) was used to normalize most 
of the samples since it was the most stable reference gene.  Aliquots were analyzed and 
quantified using CFX96 touchTm real-time PCR detection system, evaluated and 
normalized to the control (L30) by CFX manager software (Bio-Rad) or Excel (Microsoft). 
All tissue analysis experiments were done in duplicate. 
Cloning: 
Oligonucleotides obtained from IDT were used to clone each of mouse Zhx1, Zhx2 
and Zhx3 in pcDNA. In order to tag Zhx1, Zhx2 and Zhx3 DNAs with GFP sequence, the 
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cDNA of each of these genes were subcloned from pcDNA into GFP using appropriate 
restriction enzymes. The constructs were verified via DNA sequencing (ACGT, Inc.). 
Ligation:  
The following equation was used to estimate the amount of the vector and the insert: 
200 ng of the vector x X kb of the insert     x 3/1= Z 
Y kb of the vector  
X= The insert length (kb) 
Y= The vector length (kb) 
Z= The total insert mass required for the ligation  
1. The appropriate amounts of vector and insert, based in the calculation shown above, 
were added to Eppendorf tube to a total volume of 3.5 µl. 
2. 5 µl of 2x Rapid ligation buffer (c671A- Promega) was added to the reaction. 
3. 1 µl of T4 DNA ligase (M180 Promega) was used to ligate either the cohesive or 
blunt ended of 5’-phosphatase and the 3’-hydroxyl groups of the two independents 
DNA strands.  
4. 0.5 µl of nuclease free ddH2O was added to the tube. 
Transformation 
1. An aliquot of JM109 E. coli bacteria was removed from the -80 ºC freezer and 
thawed on ice. 
2. In 1.5 ml Eppendorf tube, 100 µl of the cells was added and followed by 10 µl of 
the plasmid (ligation product see above) and mixed. 
3. The mixture was incubated for 30 min on ice. 
4. The cells were heat shocked at 45 ºC for 45 seconds. 
5. The tubes were placed on ice for 2 min. 
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6.  900 µl of SOC media was added and tubes were placed in a shaker at 37 ºC for 1 
hour. 
7. During the 1 hour incubation, ampicillin plates were removed from the cold room 
(Combs building) and placed in 37 ºC incubator. 
8. After 1 hour, the cells were centrifuged at 12,000 RPM for 1 min. 
9. The supernatant was discarded and the cells were resuspended with the remaining 
media. 
10. The ampicillin plates were quickly passed over the flame to get rid of the extra 
water on the agar and the lid surfaces. 
11. Metal loop was placed at 45 angle over the flames until it turned red, then cooled 
down at the plates edges. The loop was used to culture the cells over the plates. 
12. The plates were incubated overnight at 37 ºC for colonies to grow.  
13. The plates were stored in the 4 ºC fridge for up to 3 months. 
Mini-preparation: 
Reagents:  
1. Solution I: 50 mM sucrose, 25 mM Tris pH 8, 10 mM EDTA 
2. Freshly made Solution II: 20 µl of 10 N NaOH, 100 µl 1% SDS and 0.9 ml of H2O 
Procedure: 
1. In 5 ml tubes, 1.5 ml of autoclaved LB media were added. 
2. Random colonies were picked up from the ampicillin plates and added to the LB 
media. 
3. The tubes were placed overnight in the shaker at 37 ºC. 
4. Aliquot of the cells suspension was transferred to the 1.5 ml Eppendorf tubes and 
cells were pelleted at 14,000 RPM for 1 min. 
5. The supernatant was aspirated and the cells were resuspended in 100 µl of cold 
(4ºC) plasmid preparation Solution I and mixed by inversion, vortexing and 
pipetting. 
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6. 200 µl of freshly made solution II were added to the tubes and mixed gently by 
inversion approximately for 40 seconds. 
7. 130 µl of 3M of potassium acetate (KoAc) was added and mixed via inversion until 
white precipitate was observed. 
8. In the hood, 150 µl chloroform: IAA were added and samples were shaken 
vigorously for 30 seconds. 
9. The mixture was centrifuged at 14,000 RPM for 3 min. In this step white interface 
was appeared. 
10. Using toothpick, the white precipitate was removed. Then, carefully, the lower 
organic phase was pipetted and discarded. 
11. 1 ml of 100 % ethanol was added to the aqueous phase and vortexed for 30 seconds. 
12. Sample was centrifuged for 3 min at 14,000 RPM. Supernatant was decanted, 
leaving small but visible white pellet. 
13. 100 µl of ddH2O was added to the DNA and vortexed to dissolve the DNA. 
14. 100 µl of 7.5 M NH4OAC (4 ºC) was added and mixed very well. 
15. Centrifugation at 14,000 RPM for 3 min was used to precipitate the pellet. 
16. The supernatant was removed and 95% ethanol was added to the pellet, mixed and 
spun for 1 min at 14,000 RPM. 
17. The supernatant was discarded, the pellet was slightly air dried and resuspended in 
50 µl ddH2O. 
18. After verifying the DNA concentration and purity using spectrophotometer at 260 
nm, the DNA was digested with restriction enzymes and send to ACGT for 
sequencing to confirm the constructs. After confirmation, large-scale plasmid preps 
were obtained using Maxi-prep. 
Maxi-prep: 
1. 400 ml of LB media supplemented with ampicillin (50 µg/ml) was used to grow 
bacteria overnight at 37 ºC while shaking. 
2. The next day, the bacteria were centrifuged at 4 ºC, 5000 RPM for 20 min. Qiagen 
Maxi purification kit was used to purify the plasmid according to manufacturer’s 
instructions. 
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3.  UV Spectrophotometry at 260 nm was used to determine DNA purity and 
concentration. 
 
Cell Culture:  
Primary hepatocytes and liver perfusion: 
Principal: 
In order to study the events under conditions that mimic the normal liver, primary 
hepatocytes were isolated from adult liver using the following protocol 
Reagents: 
1.Perfusion buffer I: 40 ml of 1x Hanks’ Balanced Salt Solution (HBSS) without Ca++, 
Mg++ was supplemented with EGTA (100 uM made by adding 20 µl in 40 ml). 
2. Perfusion buffer II: 40 ml of 1xHBSS (with Ca++, Mg++) was supplemented with 
phenol red 10 mg/L natural red (7:1000) dilution and (0.02 g) of collagenase (Sigma type 
IV collagenase #C-5138) was added 30 min before perfusing the mouse liver. The solutions 
were mixed and filtered into new sterile 50 ml tubes.  
Procedure was performed as described in Froh et al 2003 [113], with few 
modification: 
The VWR pump was primed at 10 RPM (Cat#54856-070), using the VWR silicone 
tube (Cat# 60985 .125x,25x63 wall) and sterile phosphate buffer saline (PBS). 
1. The perfusion I and perfusion II (freshly made) were prewarmed in the water bath 
at 37 ºC. 
2. 8-10 weeks Zhx2wt mouse was weighed and anesthetized with Avertin that consist 
of 2,2,2-Tribromoethanol 97% (Aldrich # T48402-5G) plus 2-methyl-2-butanol 
(Aldrich # 240486), via single intraperitoneal injections in amount proportional to 
the mouse weight (20 µl/ one-gram weight) during the procedure.  
3. The mouse was examined for non-responsiveness to physical stimuli. 
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4. Vertical incision was made after the animal median to open the abdominal cavity. 
5. Needle was inserted in the mouse portal vein. This was a tedious step, because the 
needle could easily move. Therefore, the needle was manually held in place until 
the end of the perfusion. 
6. The inferior vena cava was cut immediately after starting the perfusion.  
7. After the liver was perfused via perfusion I at speed 3 ml/ min, the mouse liver was 
enlarged and changed its color as clue for successful perfusion. 10 min later, the 
liver was perfused using perfusion II 5-6 ml/min for no more than 5 min. 
8. The liver was tested for successful digestion using blunt end of the scissor to press 
on the liver lobes.  
9. Then, the liver was removed from the mouse and placed in a sterile 60 mm petri 
dish with 10 ml cold DMEM media. 
10. Caution was taken to avoid cells lysis by performing the following steps at 4ºC 
unless otherwise noted. 
11. In the hood, the liver capsule was torn by forceps and gently aspirated up and down 
by a large pore pipette to break the tissue and release the cells. 
12. 100 µm cell strainer was used to filter the cells into sterile 50 ml tube. The 
undigested and connective tissues were discarded. 
13.  Then, the liver suspension was centrifuged at 25,000 RPM for 3 min using cold 
centrifuge. 
14.  The supernatant, contained non parenchymal cells (Kupffer and stellate cells), 
were collected and frozen at -80ºC until time of assay, while the pellet contained 
mainly hepatocytes (parenchymal cells) was re-suspended in 30 ml cold DMEM 
(HI Glucose Penn/Srept) and washed by centrifugation at 25,000 RPM for 3 min. 
15. After repeating washing steps for 2 more times, 100 µl of the primary hepatocytes 
were removed and diluted by adding 800 µl PBS and 100 µl of 0.5% Trypan blue 
stock. 10 µl of the mixture were examined under the microscope to estimate the 
cells number and viability. The viable cells will not take the blue color while the 
dead cells will appear as blue cells under the microscope.  
16.  Approximately 2x105 were seeded on coated six wells plates for 24hr, then treated 
per experiments. 
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Primary hepatocytes and cell lines culture: 
Cryopreserved human hepatoma (Hep3B), human cervical cancer (HeLa) and 
human embryonic kidney cells (HEK293) cells lines were obtained from American Type 
Culture Collection (ATCC) (Manassas, VA), aliquoted, stored at liquid nitrogen. To 
establish cultures, a single aliquot of frozen cells was thawed. In a T25 flask, the cells were 
cultured in either Dulbecco’s minimal eagle’s media (DMEM, media tech, Corning Cellgro 
or life Technologies) supplemented with 10% fetal bovine serum (FBS) (Fisher #03-600-
511), 1% L-glutamine and 1% Pen-Strep (Gibco) for HEK-293 cells, HeLa and primary 
hepatocytes or in RPMI 1640 (RPMI 1640) with 10% FBS for Hep3B cells. All the media, 
trypsin and the phosphate buffer saline (PBS) were preheated to 37ºC before use. Caution 
was taken to avoid cells contamination by performing all the cells handling in clean hood 
inside the tissue culture facility. All cells were maintained in an incubator set at 37 ºC and 
5% CO2.  
Transient transfections: 
  Autoclaved coverslips were placed into 12 well sterile plates. Cultured cells were 
trypsinized, resuspended in media, counted with 20x objective and 2x105 cells per well 
were seeded in the top of the coverslip. Then, the plate was shaken right-left, up-down to 
gain even cells distribution on the coverslip. After 24 hrs later, cells were at ~70-80% 
confluency.  Cells were transfected using TurboFect (Thermoscientific #R0533) following 
manufacturer’s instructions except primary hepatocytes were transfected with 
lipofectamine2000 (Life Technologies #1683449/11668-019). DNA (µg) to transfection 
reagent (µl) ratio was either 1:2 for Zhx1-GFP, Zhx3-GFP, Zhx2 or 0.5:2 for GFP and 
Zhx2. However, a 2:5 ratio was used to transfect the primary hepatocytes with all the 
plasmids in this study. Each plasmid alone was mixed with serum free media in Eppendorf 
tube and added to the wells. All the transfection assays were performed in duplicate and 
repeated at least four times. After the cells were incubated with plasmids for 48hrs, cells 
were fixed (except the primary hepatocytes; see below). 
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Cells fixation was performed as described in a protocol from Dr. Vivek Rangnekars’ 
lab (University of Kentucky, Lexington, KY) with several modifications:  
All the following steps were performed in the hood and at room temperature unless 
otherwise noted. 
1. The media was aspirated; the cells were rinsed once with warm 1x PBS to removed 
unattached cells. 
2. In the hood, cells attached to the coverslips were fixed by gently pipetting 500-600 
µl of 5% formaldehyde on the wells edges and incubated for 2-5 min. 
3. Formaldehyde was aspirated and the cells were washed twice via gently pipetting 
warm 1x PBS. 
4. The wells were slightly air-dried.  
5. Glass slides were previously washed with detergent, wiped with 70% ethanol and 
Labeled. 
6. 2 μl of DAPI H-1000 supplemented with anti-fade mounting medium (Vector 
Laboratories, Burlingame, Canada) was placed on the labeled slide. 
7. Since DAPI is light-sensitive; subsequent steps were carried out away from direct 
light. 
8. The coverslip was carefully picked up from the wells and inverted gently on the top 
of the DAPI drop with caution to avoid making bubbles. 
9. The coverslip edges were mounted using colorless nail polish and air dried for 10 
min. 
10.  The slides were frozen at -20 ºC until being examined using fluorescent 
microscope (Olympus 1x70). Pictures were captured and analyzed using pro-
capture 7 software. 
 Prediction of the proteins 3 dimensional structures and binding sites: 
 Full length mouse Zhx1, Zhx2 and Zhx3 proteins sequences were obtained from 
NCBI server (https://www.ncbi.nlm.nih.gov), and were entered in the I-TASSER website 
http://zhanglab.ccmb.med.umich.edu/I-TASSER/) [114]. I-TASSER is maintained by the 
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Zhang lab University of Michigan (Ann Arbor, Michigan). I-TASSER was used to predict 
5 simulations of each of Zhx1, Zhx2 and Zhx3 proteins tertiary structures organized from 
the highest to the lowest scores. The highest score model of each protein was visualized by 
PyMOL software (The PyMOL Molecular Graphics System, Version 1.8 Schrödinger, 
LLC) and entered into the ZDOCK server to predict the homodimer and heterodimer forms 
and the predicted protein domains. ZDOCK is endorsed and certified by Zhiping Weng’s 
lab (ZLAB) at the University of Massachusetts medical school (Worcester, Massachusetts) 
[115].  
Statistical analysis: 
GraphPad prism version 7 software for Windows, La Jolla California USA, 
www.graphpad.com, was used to average and plot the data groups in this study with 
standard deviation. In addition to performing student t-test between two groups, prism was 
used ANOVA to analyze three or more groups followed by multiple comparison using 
Tukey’s test. Chi-square analysis was employed to compare the mouse survival 
percentages compared to the expected results. Significant data denoted by star as the 
following: 0.01 ≤ *p <0.05; 0.001 ≤**p <0.01; ***p <0.001. 
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Table 2. 1 Genotyping mice primer sequences 
Gene Sequence Forward Reverse  
Zhx2 GGACCGAATCTCACTATTTAACTCA AGGCTGGCAGTGGGTTAGAAA 
  ACAACGGGTTCTTCTGTTAGTCC 
Table 2.2. Quantitative real time polymerase reaction (PCR) primer sequences 
Gene Forward Reverse 
Zhx1 ACACTTGGGAACCCCCACGACA AGTGTCATCAGGATTAGTTGGGCCC 
Zhx2 AGGCCGGCCAAGCCTAGACA TGAGGTGGCCCACAGCCACT 
Zhx3 CCAAGTGCTCCTGAGGCCAGC AGCATCCCAGACTGGCCGGT 
L30 ATGGTGGCCGCAAAGAAGACGAA CCTCAAAGCTGGACAGTTGTTGGCA 
Sfrs CTCGCACAGAGTACAGACTTAT TTGCGTCCCTTGTGAGCATCT 
Afp ATCAGTGTCTGCTGGCACGCA GGCTGGGGCATACATGAAGGGG 
H19 GGAGAGGACAGAAGGGCAGT GGAGAGGACAGAAGGGCAGT 
Cyp2a4 GGAAGACGAACGGTGCTTTC TTCCCAGCATCATTCTAAGA 
Mat1a GGCTGAAATTCCTCAAGGAGTCA GGGCAAAGAGGGAGATAGCG 
Stat5a CGCTGGACTCCATGCTTCTC GACGTGGGCTCCTTACACTGA 
Hnf4a GGAAGCTGTCCAAAATGAGCG ATGTCGCCATTGATCCCAGAG 
Stat5b GGACTCCGTCCTTGATACCG TCCATCGTGTCTTCCAGATCG 
Wt ATGACCTCCCAGCTTGAATG GTTCTCACTCTCATACCCTGTG 
Shp TCTGGAGCCTTGAGCTGT AGGGCTCCAAGACTTCACAC 
Lmx1b GCAAACAAGACTACCAACAGC AGCAGAAACAGCCCAAGTG 
Mup1 AGAAGCTACTTCCAAGGGACAG TGTCAGAGGCCAGGAGAATAGA 
MupU CAGAAGAAGCTAGTTCTACGGG GAGGCCAGGATAATAGTATGCC 
Mup18 TGACCTATCCAATGCCAATCG ACAGAACTTGTCACCCCATG 
Mup24 GTGCTGCTGCTGTGTTTGGG TGTCAGTGGCCAGCATAATAGTA 
Mup25 GCTTCTGCTCCTGTGTTTGGA CATCAGAGGCTT CAGCAATAGAA 
Mup26 GAGTGCACCGAAATGACTTTG TCCCCATCTTTTTCGTTAATGAGA 
Mcpt2 GCAGTCCCACAACATCAAAAT CAGGTAATAGGAGATTCGGGTG 
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CHAPTER 3: 
Expression of Zhx2 target genes in multiple adult tissues of Zhx2+ and Zhx2- mice 
Previous studies in our laboratory examined the expression of Zhx2 target genes in 
the liver using different mouse models.  These studies initially used BALB/cJ mice, which 
have a hypomorphic Zhx2 mutation that results in elevated AFP expression in the adult 
liver [43]. This mutation is specific to BALB/cJ since Zhx2 is expressed normally in the 
highly related strains BALB/c/BOM and BALB/cBy [40]. When placed on a high fat diet, 
BALB/cJ mice have lower serum lipid levels and reduced atherosclerotic plaques 
compared to other mouse strains; a trait that has been mapped to a locus called 
Hyperlipidemia 2 (Hyplip2) [116].  In collaboration with the lab of Jake Lusis, we have 
shown that the Hyplip2 phenotype in BALB/cJ mice is due to the Zhx2 mutation [48].  In 
contrast to the cardiovascular phenotype, BALB/cJ mice have increased liver lipid 
accumulation and liver damage compared to other mouse strains when placed on a high fat 
diet [Creasy, Clinkenbeard and Spear, unpublished]. These data indicate that Zhx2 is 
hepatoprotective in mice on a high fat diet. [48].  
In studies with BALB/c and BALB/cJ mice, our lab identified Cyp8B1 
[Clinkenbeard Thesis, 2012], lipoprotein lipase (Lpl) and Elongation of very long chain 
fatty acids like 3 (Elovl3) [Ren Thesis, 2012] as targets of Zhx2 in the liver.  Using liver-
specific Zhx2 knock-out mice Zhx2Δhep that were developed in our lab, we found that Zhx2 
also regulates sex-biased expression of Cytochrome p450 steroid 15α-hydroxylase 
(Cyp2a4). These studies suggest cross-talk between Zhx2 and methionine 
adenosyltransferase 1a (Mat1a), and Hepatocyte nuclear factor 4a (Hnf4a) and signal 
transducer and activator of transcription 5a and 5b (Stat5a and Stat5b) [Creasy Thesis, 
2015]. To date, most of the research on Zhx2 has focused on the liver since many Zhx2 
target genes are expressed primarily in this organ.  However, Zhx2 is expressed in multiple 
tissues, suggesting that Zhx2 might regulate genes in tissues other than the liver.  The major 
focus of this Chapter is to analyze expression of Zhx2 and the highly related Zhx1 and 
Zhx3 genes in multiple tissues and the expression of potential Zhx2 target genes in whole-
body Zhx2 knock-out (Zhx2ko) mice. 
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Numerous hepatic genes exhibit sex-biased expression and are controlled by 
pituitary hormones, including growth hormone (GH), Luteinizing hormone (LH) and 
follicle stimulating hormone (FSH) [117].  Examples include the Cytochrome P-450 (Cyp) 
enzymes, a large family comprised of 57 genes and 58 pseudogene in humans [118] and 
102 genes and 88 pseudogenes in mice [119]. Cyps are expressed in many organs but 
expressed at the highest level in the liver. Cyps are clinically important since they 
metabolize a number of pharmaceutical drugs. Many Cyps, which metabolize drugs and 
non-xenobiotics [118], are expressed differently in males and females. For example, 
females express Cyp2A4 [120] while males express Cyp2d9 in the liver.  Cyp2A4 is also 
expressed in the kidney and lungs [121].  Human kidneys express other CYPs, including 
CYP2B6 and CYP3A5, the latter has clinical importance since it metabolizes certain 
tyrosine kinase inhibitors such as dasatinib [55].  
Beside metabolizing xenobiotics, CYP4A catalyzes the ω-hydroxylation of excess 
long chain fatty acids, producing dicarboxylic acid [122].  Moreover, CYP4A is important 
for renal vascular and tubular function and controls blood pressure by forming 
hydroxyeicosatetraenoic acis (20-HETE).  In C57BL/6 mice, Cyp4a12a is expressed four-
fold higher in males than in females. In contrast, Cyp4a10 and Cyp4a14 are highly 
expressed in females.  Males and female kidneys do not appear to express Cyp4a12b [123]. 
Besides the liver and kidney, some mouse Cyps are expressed in the  duodenum and 
jejunum [121]. Using Zhx2Δhep mice, our lab demonstrated that sexually dimorphic Cyp2a4 
expression was regulated by Zhx2.  Specifically, low Cyp2a4 expression in adult male liver 
is controlled, at least in part, by Zhx2 since expression of this Cyp increases in the male 
liver of Zhx2Δhep male mice [Creasy Thesis, 2015]. These studies led us to consider whether 
Zhx2 might control expression of Cyps and other genes in the kidney and small intestine 
of males and female mice. 
As mentioned earlier, studies in our lab suggest a possible relationship between 
Zhx2 and Stat5 proteins.  Two Stat5 isoforms (Stat5a and Stat5b) exist in the liver, both of 
which are controlled by growth hormone. Stat5a regulates liver metabolism and 
inflammatory gene expression in female mouse liver but does not play a role in the male 
mouse liver [124]. Stat5b controls genes in the male mouse liver and  knocking it out causes 
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a developmental delay [124]. Interestingly, elevated levels of Janus kinase 2 (Jak2), Stat1, 
Stat3, Stat5a and Stat5b have been observed in hyperglycemic diabetic rat kidney [125].  
These data have led us to consider whether Zhx2 could regulate Stat5 in the liver, kidney, 
brain and small intestine. 
Several investigators have studied Zhx1, Zhx2 and Zhx3 in various organs such as 
liver, brain, kidney and blood [43], [65],[126], [76], [127]. Independent investigations have 
revealed two genes, Wilms tumor (Wt) and Lim homeobox transcription factor 1 beta 
(Lmx1b), to be inversely correlated with Zhx2 in in vitro experiments [53].  
 Wilms tumor (Wt1), a transcription factor, is expressed highly and specifically in 
kidney podocytes. Wt1 is a zinc finger protein that plays a role in transcriptional and 
posttranscriptional events. It is important for normal kidney function [53] and has been 
correlated with hematological disorders [128]. Mutations in Wt1 in the mouse germline 
results in embryonic lethality due to development of Wilms tumor and abnormalities in 
kidney, genital system, mesothelium, heart and lungs [129]. Interestingly, Wt1 is expressed 
in the fetal liver but silenced after birth. However, its expression is increased in liver 
fibrosis, hepatitis and cirrhosis. Moreover, an inverse correlation exists between Wt1 and 
HNF4a in the liver [130]. Given that, Zhx2 is involved in repressing several genes that are 
usually expressed in the fetal liver and shut down after birth and that Zhx2 is ubiquitously 
expressed [43], I hypothesized that expression of Wt1 could be altered in Zhx2ko liver and 
kidney in comparison to Zhx2wt mice. 
The Lmx1b gene is involved in the normal development of brain, limbs, eyes, and 
kidney. Mouse studies indicate that vertebrate dorsal-ventral pattering is driven by Lmx1b, 
in partnership with Wnt signaling.  Lmx1b knock-out mice have dorsal skin on their paws 
with ventral skin on both dorsal and ventral sides; this is due to the lack of Lmx1b that is 
usually expressed in the dorsal mice mesenchyme [131]. In human, mutated LMX1B 
causes developmental defects in a disease termed nail-patella syndrome [132]. Podocyte-
specific Lmx1b knock-out mice have scattered actin cytoskeleton in podocytes [132]. 
Lmx1b is moderately downregulated after Wt1 downregulation in the Puromycin 
aminonucleoside nephrosis (PAN) plus Passive Heymann nephritis (PHN) rat model [126]. 
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Shp is the orphan nuclear receptor encoded by the Nrob2 gene. It belongs to the 
nuclear receptor family but does not possess a DNA binding domain and therefore must 
interact with other nuclear receptors but does contain at least one putative ligand binding 
domain. Shp functions as a repressor of numerous liver functions such as bile acid, 
cholesterol, lipid and glucose metabolism [133]. SHP usually functions as a repressor in 
the liver by heterodimerizing with nuclear receptors and block their interactions with co-
activators and enhancing binding with co-repressors. For example, glutathione-S-
transferase pull-down experiments have shown that SHP can bind and repress the liver X 
receptor (LXR) [134]. 
Using in situ hybridization, the SHP gene has been localized to chromosome 1p36.1 
in humans and chromosome 4 in mice.  Human and mouse SHP genes are 77% conserved 
and contain two exons spanning 1.8 and 1.2 kilobase (Kb), respectively. In human, SHP is 
expressed in the fetal liver and fetal adrenal gland [135], and adult liver [136], spleen and 
small intestine [135]. Since H19 in the liver is repressed by Zhx2 [43] and by Shp [136], I 
hypothesized that a correlation could be exist between Zhx2 and Shp. 
In summary, analysis of gene expression patterns in multiple organs of whole-body 
Zhx2 knock-out mice might shed light on the role of Zhx2 in regulating genes that influence 
behavior, cancer and cardiovascular disease. Examination of several known targets of Zhx2 
expressions in hepatic and non-hepatic tissue will provide a better understanding of Zhx2 
function.  
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Results 
AFP levels are increased in the adult liver of whole body Zhx2ko mice: 
Our lab previously identified AFP and H19 as targets of Zhx2 in the liver due to 
the observation that BALB/cJ mice have increased AFP and H19 in the adult liver and 
decreased Zhx2.  Introducing a liver-specific Zhx2 transgene into BALB/cJ mice results in 
normal AFP and H19 silencing after birth [43]. Therefore, to validate the use of whole 
body Zhx2ko mice for my studies, I first analyzed hepatic expression of AFP and H19 in 
male and female adult liver of Zhx2wt and Zhx2ko mice. First, RT-qPCR conformed the 
absence of Zhx2 in Zhx2ko liver (Figure 3.1). Consistent with BALB/cJ mouse data, AFP 
levels are significantly increased (p=0.04). Although not statistically significant due to 
small sample number, H19 mRNA levels were increased in liver of Zhx2ko mice compared 
to Zhx2wt mice (p=0.06; Figure 3.1).  Increasing the mouse sample size would likely result 
in the H19 difference to reach significance. This expression of AFP and H19 mRNA levels 
validate the use of Zhx2ko mice as a model to examine Zhx2 target gene expressions. 
Zhx1 is expressed in multiple organs of male and female Zhx2wt mice: 
We used RT-qPCR to evaluate Zhx1 mRNA levels in the kidney, small intestine 
(SI), salivary gland (SG) and lacrimal gland (LG) of age matched male and female Zhx2wt 
mice.  In males, Zhx1 mRNA levels were found to be the highest in the kidney and lowest 
in the SG and LG; Zhx1 levels in the SI were slightly higher than the SG (Figure 3.2 A). 
In females, Zhx1 expression was higher in SI compared to the kidney and SG (Figure 3.2 
B). In fact, females have significantly higher Zhx1 mRNA levels than males in the SI. 
These results raise the question whether Zhx1 is a female-biased gene in SI (Figure 3.2 C). 
Zhx2 is ubiquitously expressed in adult male and female Zhx2wt mice: 
Utilizing Northern blot analysis, our lab previously demonstrated that Zhx2 is 
ubiquitously expressed in the brain, thymus, heart, lung, liver, spleen, gut, kidney, muscles 
and testis [43]. I used RT-qPCR to confirm these results in five organs of adult Zhx2wt male 
and female mice. In males, the highest Zhx2 expression was detected in the kidney and SI. 
34 
 
Liver Zhx2 expression levels were low and almost equal to that seen in brain. The lowest 
expression was detected in the SG and LG (Figure 3.3 A). The highest Zhx2 expression 
level of female mice were observed in the SI and it is slightly higher than SI expression in 
male. Female Zhx2 expression in the liver, kidney and brain show similar expression 
levels, while the lowest Zhx2 levels were in the SG (Figure 3.3 B). In conclusion, although 
not statistically significant, male kidney has slightly higher Zhx2 levels than the female 
kidney, while SI Zhx2 levels are slightly higher in females than in males (Figure 3.3 C). 
Zhx3 is expressed in several organs of Zhx2wt mice: 
 In order to quantify and compare the expression level of Zhx3 in various mice 
organs, I performed RT-qPCR analysis in several male and female organs. Zhx3 was 
expressed at substantially higher levels in the kidney of male mice compared to the SI, SG 
and LG (Figure 3.4A). Females kidney exhibited higher Zhx3 levels than SI (Figure 3.4B). 
Zhx3 mRNA levels were almost equal between male and female kidney and small intestine 
(Figure 3.4C). 
Mups are candidate Zhx2 targets in the liver: 
 Our lab previously demonstrated that BALB/cJ mice have a hypomorpic mutation 
in the Zhx2 gene. To test whether BALB/cByJ and BALB/c substrains have normal Zhx2 
genes, I used RT-qPCR to analyze gene expression in the adult livers of these 3 closely 
related substrains. My analysis indicates that Zhx2 is expressed normally in BALB/cByJ 
and BALB/c mice, while BALB/cJ mice, as expected, express very low Zhx2 levels.  
Consistent with this, adult liver AFP and H19 mRNA levels were low in mice that express 
Zhx2. MUP24, which we have found to be positively regulated by Zhx2, is lower in 
BALB/cJ mice compared to the other two groups (Figure 3.5).  
Mups are upregulated in the SG of Zhx2ko male mice:  
Several groups have examined expression of Mups in the liver, SG and LG [86, 87, 
95, 97]. BALB/cJ mice secrete low Mup levels [82], which are known to influence male 
behavior such as aggression. Genetic analysis has identified one locus that regulates this 
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behavior, at least in part, near the D15Mit46 microsatellite marker [83]. Zhx2 is also close 
to this marker. Preliminary data has shown that Zhx2 is a positive regulator of Mup 
expression in the liver [Spear unpublished data]. Since several Mups are also expressed in 
the SG, we examined Mup expression in the SG of Zhx2wt and Zhx2ko mice. 
Mup1 and Mup18 are expressed in the SG [97]. Therefore, I performed RT-qPCR 
to analyze expression of these Mups in the longitudinal half of mouse SG that consists of 
parotid, submandibular and sublingual gland. I confirmed that Zhx2 is absent in SG of 
Zhx2ko male mice. Notably, I found that Mup1, Mup18, Mup24 and class B Mups (MupU) 
were increased in the absence of Zhx2. No difference was observed for Mup25 (Figure 
3.6). This inverse relationship between Zhx2 and Mup expression in SG was quite 
surprising since Mups are positivity regulated by Zhx2 in the liver.    
MUPs are upregulated in the Zhx2ko female mice SG: 
A significant negative correlation was observed between Zhx2 and Mup1 and 
Mup18 but not Mup24 or Mup25 in the female salivary gland (Figure 3.7).  Expression of 
Mup1, Mup18 and Mup25 are nearly equal in male and female SG, while Mup24 
expression is higher in female SG; Class B Mups were not tested in female. This data 
suggests the lack of sexual dimorphism of Mup expression in the SG (Figure 3.8) as 
compared to a big difference in Mup expression between male and female liver (Figure 
3.15 B).  
The absence or the presence of Zhx2 does not alter the gene expression of Zhx1, Zhx3 
and H19 in the mice SG: 
I considered whether the absence of Zhx2 would alter the expression of the highly 
related Zhx1 and Zhx3 genes in SG. However, Zhx1 and Zhx3 mRNA levels did not change 
in Zhx2ko SG in either male or female mice. It is worth noting that Zhx1 and Zhx3 were 
expressed at higher levels than Zhx2 in SG of both male (Figure 3.9) and female (Figure 
3.10) mice. There is no gender bias in the expression of Zhx1 (Figure 3.2 C) and Zhx2 
(Figure 3.3C) in SG. Previous studies have shown that H19 levels increase in the absence 
of Zhx2 in the adult liver. However, H19 levels showed a slight but not significant increase 
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in SG of both male (Figure 3.9) and female mice (Figure 3.10). Curiously, H19 mRNA 
levels were elevated in SG of the pleomorphic adenomas in PLG1 transgenic mice [137] 
and are often elevated in HCC.  
A trend towards a negative correlation between Zhx2 and MUP1 expression in male 
lacrimal glands (LG): 
Since Mup1 is abundantly expressed in the LG [95], I examined Mup1 expression 
in Zhx2ko and Zhx2wt mice. While Mup1 levels increased slightly in Zhx2ko LG, this change 
was not significant (p= 0.07). The mRNA levels of class B Mups, Mup18, Mup24 as well 
as Zhx1 and Zhx3 did not show any difference between Zhx2ko and Zhx2wt mice (Figure 
3.11). In summary, I found that Mup1, Mup18, class B Mups, and, to a lesser extent, 
Mup24, are expressed in male LG; of these, Mup1 is the most abundantly expressed. In 
contrast, Mup18 is the most abundant Mup in SG (Figure 3.12). Other Mups have not been 
investigated. My data is consistent with previous studies showing that MupIV, which is 
likely Mup1 [99], is the most abundant Mup in lacrimal glands [97]. As with the SG, we 
have found that Zhx1 and Zhx3 are expressed at higher levels than Zhx2 in LG; expression 
of these two Zhx genes do not change in Zhx2ko mice (Figure 3.11).  
Mups are not regulated by Zhx2 in the male liver: 
My data indicate that several Mup genes are negatively regulated by Zhx2 in SG.  
In contrast, previous studies in our lab indicate that Mups are positively regulated by Zhx2 
in the liver. Consistent with this result, I found that Mup expression is lower in adult 
BALB/cJ liver compared to BALB/c and BALB/cByJ (Figure 3.5). Therefore, I examined 
Mup expression in Zhx2ko and Zhx2wt mice (Figure 3.13). In contrast to my studies in 
BALB substrains and previous studies in knock-out mice (Jiang, submitted), I found no 
difference in Mup expression between Zhx2ko and Zhx2wt mice. Consistent with previous 
studies, I found that class B Mups (MupU) are the most abundant liver Mups, with Mup24, 
Mup25 and Mup26 also being highly expressed (Figure 3.13).  
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Mat1a mRNA levels are decreased in adult male Zhx2ko mouse liver: 
 Most of our knowledge about Zhx2 comes from studies in BALB/cJ mice, which 
have a natural mutation in Zhx2. For instance, BALB/cJ male mice have increased 
production of Cyp2a4 [138].  Moreover, Kate Creasy, a former student in our lab found 
that expression of Mat1a, Stat5a and Stat5b genes were decreased in hepatocyte-specific 
Zhx2ko (Zhx2Δhep) mice [Creasy Thesis, 2015]. This led me to test whether Cyp2a4, Mat1a, 
Stat5a and Stat5b were altered in Zhx2ko mice. I did not observe a significant change in 
Cyp2a4, Stat5a or Stat5b expression. However, I did observe a significant decrease in 
Mat1a mRNA levels in Zhx2ko liver (Figure 3.14). Shp is a critical factor in liver lipid 
homeostasis and it negatively correlates with Cyp8B1 expression [139], a negative 
correlation exists between Shp and Cyp8B1in cholestasis [140], Cyp8B1 was correlated 
with Zhx2 in BALB/cJ mice [Clinkendeard Thesis, 2012]. Therefore, I investigated Shp 
mRNA levels in Zhx2ko male liver. I found no change in Shp levels, indicating that Shp is 
not a target of Zhx2 in male liver (Figure 3.14).  
The Emr1 gene encodes a 160 KD macrophage-specific cell surface glycoprotein 
[141]. A correlation between elevated H19 and increased hepatic macrophage numbers has 
been reported [136]. Since Zhx2 negatively regulates H19 [43], I tested whether Emr1 
levels would increase in livers of Zhx2ko mice. However, Emr1 mRNA levels were not 
altered in liver of Zhx2ko as compared to Zhx2wt mice (Figure 3.14). 
Hepatocyte nuclear factor 4 alpha (HNF4α) is an important liver-enriched 
transcription factor [142]. HNF4 mRNA is highly expressed in the liver, kidney, brown 
and white adipose, muscle, stomach, tongue, duodenum, jejunum, ileum, colon and gall 
bladder [143]. Zhx2Δhep mice liver exhibited a significant positive correlation between 
Zhx2 and Hnf4α [Creasy Thesis, 2015]. However, I found no change in HNF4α in Zhx2ko 
liver (Figure 3.14). 
Mup24 is positively regulated by Zhx2 in the adult female liver: 
Class B Mups (MupU) and Mup24 were expressed at higher levels than Mup1 and 
Mup18 in adult female liver (Figure 3.15A). Mup24 was significantly decreased in Zhx2ko 
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female liver, whereas none of the other Mups changed in the absence of Zhx2. Mups are 
expressed at higher levels in the male liver than in female liver.  My data also indicates that 
class B Mups (MupU) and Mup24 were higher in male liver than in female liver (Figure 
3.15B)  
Zhx2 is positively correlated with Mat1a and inversely with Shp, lipid metabolism 
genes, in the female mice livers: 
As described in Figure 3.14, we analyzed several different hepatic genes in Zhx2wt 
mice Zhx2ko mice. We also analyzed these same genes in female livers to see if their 
expression changed in the absence of Zhx2. As expected, Zhx2 mRNA levels were 
significantly reduced in Zhx2ko female liver. Mat1a levels exhibited a significant decrease, 
Shp levels exhibited a trend toward a negative regulation in the absence of Zhx2, whereas 
all other genes were not affected by the loss of Zhx2 (Figure 3.16)  
Analysis of candidate Zhx2 targets in the kidney: 
Several reports indicate that expression of Zhx proteins are altered in rodent models 
of kidney disease [126]. We were interested in analyzing Zhx target genes, as well as Zhx1 
and Zhx3, in Zhx2ko mice. While Zhx2 levels were dramatically reduced in Zhx2ko mice, 
as expected, we did not see any changes in the other genes that were analyzed (Figure 
3.17). These include Mup24, H19 and AFP, which are known targets of Zhx2 in the liver. 
Zhx1 and Zhx3 are expressed much higher than Zhx2 in the kidney, but do not change in 
the absence of Zhx2. We were particularly interested in Wt1 and Lmx1b due to their 
important role in kidney development and disease. However, I found no correlation 
between Zhx2, Wt1 and Lmx1b (Figure 3.17). Similar results were observed in female 
mice except Stat5b which has shown a trend towards a positive correlation with Zhx2 status 
(Figure 3.18).   
Zhx2 control gene expression in the brain: 
  I was interested to examine whether expression of Zhx2 and Zhx2 target genes is 
altered in the brain. I was particularly interested in Mat1a, Shp, and Cyp2a4. Although 
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previous northern blot studies indicated that Mups were not expressed in the brain or other 
organs, [95] [86], preliminary RT-qPCR studies from our lab indicated that Mups were 
expressed in the brain [Data not shown]. Levels of Cyp2a4, Mat1a, Shp, Mup1, class B 
Mups (MupU), Mup18, Mup24, Mup25 and Mup26 mRNA in the brain of Zhx2wt and 
Zhx2ko mice were analyzed by RT-qPCR. Mups were expressed at very low levels in the 
brain compared to liver. Mup 24, Mup25 and class B Mups (MupU) were decreased in the 
absence of Zhx2, although none of these differences were statistically significant. None of 
the other genes tested were affected by the absence of Zhx2, although Shp showed a modest 
but insignificant decline (Figure 3.19). Similar studies were performed in female brain 
samples. The fact that females Mup mRNA levels were lower than males is expected, since 
it has been documented that females express lower level of MUPs than males [99] [95]. 
However, none of the candidate Zhx2 target genes exhibited significant differences in 
expression in Zhx2ko mice (Figure 3.20).  
Expression of Zhx genes and Zhx2 target genes in small intestine: 
A number of Zhx2 target genes, including AFP and H19, are expressed at low but 
detectable levels in the small intestine (SI).  Previous northern analysis suggested that these 
targets were not affected by Zhx2 in this tissue. Since RT-qPCR is a more sensitive measure 
of gene expression, I decided to analyze Zhx2 and Zhx2 targets, as well as other Zhx genes, 
in the small intestine. Despite the dramatic decline of Zhx2 mRNA levels in Zhx2ko mice, 
none of the other genes analyzed, including AFP and H19, showed a change in expression 
in the absence of Zhx2. I also found that Zhx1 and Zhx3, whose levels were much higher 
than Zhx2, did not exhibit any compensatory change in Zhx2ko mice. Mast cell protease 2 
(Mcpt2) is an enzyme secreted by Mast cells and is usually activated in allergy or parasite 
infection. Previous studies reported that Mcpt2 is not secreted in the SI. However, 
BALB/cJ mice will secret Mcpt2 after helminth infection [144]. Therefore, I tested whether 
Mcpt2 expression would be higher in Zhx2ko SI as compared to Zhx2wt mice. However, I 
observed no correlation between Zhx2 and Mcpt2 (Figure 3.21).  
I also analyzed Zhx2 and Zhx2 target genes in SI of adult female mice. Despite the 
dramatic decline in Zhx2 mRNA levels in Zhx2ko SI, no significant change in AFP, H19, 
40 
 
or Cyp2a4 was observed. As was observed in male mice, SI expression of Zhx1, which is 
much higher than Zhx2, was not affected by the absence of Zhx2 (Figure 3.22).  
Discussion:  
One goal of my dissertation is to understand how Zhx2 regulates target gene 
expression. In particular, since much of the previous work in our lab has focused on the 
liver, I analyzed expression of Zhx2 and Zhx2 target genes in tissues other than the liver.  
These studies utilized Zhx2ko mice that have been generated in our lab. This is the first 
report utilizing Zhx2ko mice as previous studies utilized BALB/cJ mice [Clinkenbeard 
Thesis, 2012] and Zhx2Δhep mice [Creasy Thesis, 2015]. I demonstrated increased hepatic 
AFP and H19 expression in Zhx2ko mice as compared to age-matched Zhx2wt mice. These 
data are consistent with our previous findings which indicated that Zhx2 is required for 
postnatal silencing of AFP and H19 expression in the liver [43]. Moreover, my finding 
validates Zhx2ko mice as a good model to study Zhx2 regulation of target genes in multiple 
organs.  
Since Zhx2 is closely related to Zhx1 and Zhx3 [145], we analyzed expression of 
these genes in various tissues. We found that both genes were ubiquitously expressed but, 
similarly to Zhx2, their expression varies between tissues. The fact that male Zhx1 
expression was highest in the kidney was not surprising since Zhx1 has been implicated in 
normal kidney podocyte function. Other studies also found Zhx1 to be expressed at higher 
levels in kidney than in small intestine [47]. In contrast to males, my data indicates that the 
highest Zhx1 expression in females occurred in the SI. The human protein atlas database 
indicates that the highest Zhx1 mRNA levels are found in the gastrointestinal track, 
although this study did not signify sex (http://www.proteinatlas.org/ENSG00000165156-
ZHX1/tissue). There is no published information regarding Zhx1 expression in the small 
intestine.  
We did not test Zhx1 in the brain, but other investigators used Northern blot 
analysis to show that Zhx1 is highly expressed in the brain, with lower expression found 
in the liver and kidney and undetectable levels in the heart and muscle [145] [49]. 
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Interestingly, human ZHX1 was observed in all organs tested with the highest level in the 
heart, skeletal muscle and pancreas. However, other studies indicate that Zhx1 is 
moderately expressed in the brain, kidney and placenta with lower levels in the lung and 
the liver [50]. In conclusion, further studies may be needed to further examine Zhx1 
expression in numerous organs. 
Altered cellular localization of Zhx2, as well as Zhx1 and Zhx3, has been observed 
in Passive Heymann nephritis (PHN) and Puromycin amino nucleoside nephrosis (PAN), 
two rat models of kidney disease [126]. These data raise the possibility that Zhx2 could 
play a role in normal kidney function. My data showing that Zhx2 is expressed at higher 
levels in the male kidney than other organs is consistent with this possibility. In contrast, 
Zhx2 mRNA levels are highest in the female small intestine. My data is consistent with our 
previous Northern blot analysis showing Zhx2 to be highest in the kidney, although it is in 
contrast to our earlier data showing brain Zhx2 mRNA levels to be higher than the liver 
[43]. I believe that real time qPCR is more accurate than Northern blot. Also, my data is 
similar to some of the data in the human protein atlas, although they did not state the sex 
of the samples. This database showed that Zhx2 mRNA is comparable between kidney and 
small intestine, but also noted that SG express high Zhx2 levels 
(http://www.proteinatlas.org/ENSG00000178764-ZHX2/tissue). It is possible that these 
differences are due to variations in gene expression between men and women. Previous 
studies from our lab suggest that Zhx2 regulates sex-biased differences of hepatic Cyp 
enzymes and may cross-talk with Stat5a and Stat5b [Creasy Thesis, 2015], which are 
controlled by circulating growth hormone [146]. Zhx2 regulates Mup expression in the SG 
and LG (this Chapter) and in the liver [Jiang and Spear, submitted] and Mups are  regulated 
by hormones [95].  
I was not surprised to find the highest Zhx3 mRNA levels in the kidney compared 
to the small intestine in both sexes and to SG and LG glands males. Other investigators 
reported that Zhx3 regulates Wt1, an important podocytes gene, and correlated with 
nephrotic syndrome disease [53].  In support of this, Northern blot analysis showed human 
ZHX3 to be highly expressed in the kidney [47]. These data are consistent with human 
protein atlas that showed ZHX3 to be expressed in the kidney at twice the levels seen in 
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the small intestine. This data raises the possibility that Zhx3 could play a critical role in the 
kidney. 
Overall, my data indicates that Zhx1 and Zhx3 are expressed at higher levels than 
Zhx2 in all the organs that I tested. Although there is no published data describing the 
function of Zhx1, Zhx2 or Zhx3 in the SI, SG and LG, my results suggest that Zhx1 and 
Zhx3 may be more important than Zhx2 and support further investigation of these Zhx 
proteins in multiple organs, including the liver. 
Although Mup genes are not found in humans, there are reasons to study these 
genes. Mups are highly expressed in mouse liver and other glands; therefore, studying 
Mups could reveal important clues about gene regulation in these organs. In addition, 
behavior and physiological processes in humans, especially woman, are influenced by 
pheromones. Menstrual synchrony is a phenomenon in which pheromones from one 
woman can alter the ovulation cycle time of other females. The same phenomenon has also 
been reported in rats [100].  
I focused on analyzing of Mup1 and Mup18 in the salivary glands since Logan et 
al found these two genes to be expressed in this tissue [99]. My data are novel in showing 
that Mup18 is the highest expressed Mup in the SG.  Mup1 and class B Mups are the second 
and third highest expressed Mups in this tissue, respectively. My data showing Class B 
Mup expression in SG is in support with Logan et al that documented that MUP3(Class 3 
MUP) is expressed in the submaxillary glands. In SG, Mup18 expression is greater than 
Mup1. Unfortunately, I have not tested class B Mups in female salivary gland, but this 
should be done in future studies. High Mup24 levels in the SG of females but not males 
was surprising since it has been reported to be expressed in male C57BL/6J liver and 
submaxillary glands [99]. A more careful developmental analysis of Mup expression in the 
salivary gland may be warranted since Mup RNA production has been reported to start at 
one weeks of age in mice, increase over time but decrease at six months of age [95]. A time 
course study in liver found that Mup24 is activated after birth and gradually increases up 
to a high level on day 56, a pattern similar to Zhx2 and opposite to AFP [Jiang and Spear, 
submitted].   
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Mup expression in the salivary gland is not sexually dimorphic, which strongly 
suggests a lack of hormonal regulation of Mups in this tissue. My data are consistent with 
previous Northern blot data showing male biased Mup expression in the liver and lacrimal 
gland but not in submaxillary glands [95]. Future studies should analyze Mup expression 
changes in the absence of Zhx2 in the lacrimal gland. 
Prior to my studies, little was known regarding the role of Zhx2 in non-hepatic 
tissue, including SG and LG. My data revealed a novel significant negative correlation 
between Zhx2 expression and Mup1, Mup24 Mup18 and class B Mups in males and Mup1 
and Mup18 in females. This is in contrast to what is observed in the liver. These findings 
support a model in which higher Mup expression in SG of male BALB/cJ mice could 
explain their high aggression [82]. Further studies should further test this possibility.  
Mup expression in mouse submaxillary gland begins one week after birth and is 
free from hormonal regulation. Shaw et al 1982 [95] treated hypophysectomized mice with 
testosterone, thyroxin and growth hormone. Surprisingly, none of these hormones 
influenced Mup expression in the submaxillary glands, which are a component of the SG 
that was studied in this Chapter.  
Zhx1 and Zhx3 levels were not altered in SG of Zhx2ko mice, indicating that there were no 
compensatory changes in the expression of these related genes when Zhx2 was no longer 
expressed. This is similar to what was seen with Stat5 genes, which are more than 90% 
similar. Stat5a could not compensate for Stat5b in Stat5b knockout mouse liver [124].   
While Mups are expressed at highest levels in the liver, these genes are also 
expressed in LG and SG although the liver and these glands expressed different Mup genes.  
Since Zhx2 positively regulates Mup expression in the liver, I hypothesized that Mups were 
also be positively regulated by Zhx2 in SG and LG.  However, I was surprised to find that 
Mups appeared to be negatively regulated by Zhx2 in these tissues. In male SG, Mup1, 
Mup18 and class B Mups (MupU) increase in the absence of Zhx2.  For class B Mups and 
Mup18, this difference was significant. Mup24, which is liver-specific, is expressed at very 
low levels in Zhx2wt mice but increased in Zhx2ko mice.  A similar pattern is seen in female 
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SG; Mup1 and Mup18 are expressed at higher levels in Zhx2ko SG than in Zhx2wt SG.  In 
contrast to SG, we did not see any change in Mup expression in the LG of Zhx2ko mice.  
The fact that LG is under hormonal regulation while SG is not might explain the difference 
in gene expression. Although I have not analyzed the females LG samples, I would expect 
them to express less Mups since previous Northern blot analysis showed Mups to be 
expressed 5-fold higher in the LG of male mice compared to female mice [95]. Experiments 
in hypophysectomized mice showed that lacrimal gland Mup expression can be restored 
by testosterone only [95]. My RT-qPCR data is consistent with previous northern blot 
studies showing that Mup1 is most abundantly expressed in LG, while Mup18 is the major 
Mup in SG  [97].   
It is known that Mups control a number of behaviors in mice. In addition, Zhx2 has 
been associated with certain mouse behaviors, including male-on-male aggression. My 
data propose that the correlation of Mups in SG and LG with Zhx2 might help explain these 
associations since Mups mediate mice communication. 
Most studies on Zhx2 have been performed in the liver, and it is clear that Zhx2 has 
an important role in controlling target genes in this organ. Since Zhx2 controls H19 in the 
liver [43] and it was found that livers with elevated H19 had in influx of macrophages 
[136], I considered whether the lack of Zhx2 could induce macrophage accumulation in 
the liver. To test this, I analyzed expression of Emr1, a macrophage marker. However, I 
found no change in Emr1 expression in Zhx2ko livers compared to the liver of Zhx2wt mice.  
Perhaps immunohistological staining with macrophage-specific antibodies of Zhx2ko and 
Zhx2wt livers could reveal differences in macrophage accumulation.  
I analyzed the expression of several liver genes in male and female Zhx2ko mice 
that were previously tested in hepatocyte-specific (Zhx2Δhep) mice [Creasy Thesis, 2016]. 
I found no significant change in expression of Cyp2a4, Mups, Hnf4, Shp, Stat5a or Stat5b.  
Hnf4 is a critical regulator of genes involved in numerous, essential liver functions 
including bile acid, lipid metabolism, gluconeogenesis, amino acid and blood coagulation 
factors. Hnf4 null mice die prenatally due to the development of sever hepatomegaly and 
steatosis [147]. Our lab previously found that Cyp2a4 levels were increased in the adult 
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male liver of Zhx2Δhet mice, but I saw no significant change in adult male liver of Zhx2ko 
mice. There must be differences in how these genes are regulated in the liver depending on 
whether Zhx2 is absent in all liver cells or just hepatocytes. However, I did find a 
significant decrease in Mat1a in both male and female liver in Zhx2ko mice. Previous 
studies by our collaborator in China indicate that nuclear Zhx2 protein levels are decreased 
in HCC. It is also known that Mat1a is reduced in NAFLD, NASH [36], liver steatosis [33] 
and HCC [37]. These data suggest a possible link between Zhx1 and Mat1a in HCC.    
My data supports previous studies indicating that class B Mups, Mup24, Mup25 
and Mup26 are highly expressed in male liver.  I cannot explain why I did not see a decrease 
in Mup expressioin in the absence of Zhx2, since previous studies in our lab showed that 
Mup levels are dramatically reduced in the absence of Zhx2, except my studies have 
utilized different mice. 
In adult female liver, my data indicates that Mup24 levels were significantly lower 
in the absence of Zhx2. It is not known why we saw a difference in Mup expression in 
female mice but not male mice when Zhx2 was deleted.    
I was particularly interested in the kidney, since previous studies showed changes 
in Zhx protein expression in several models of kidney disease. I found that Zhx1 and Zhx3 
were expressed at much higher levels than Zhx2 in the kidney. This might explain why 
levels of these two genes did not change in Zhx2ko kidney. Despite the similarities in Zhx 
proteins, we do not yet know the extent to which their functions overlap. ChIP-seq might 
shed some light on possible overlapping targets of different Zhx proteins. Also, staining 
Zhx2ko mice kidney with Zhx1 and Zhx3 antibodies, could help determine if their cellular 
localization have been altered in absence of Zhx2. It has been reported that elevated Zhx1 
and Zhx2 podocyte nuclear expression is observed in a proteinuric rat model. In other 
models of kidney disease (PAN plus PHN rat model) Zhx2 and Zhx3 were marginally 
increased and Zhx1 was downregulated [126]. This is partially supported by my data as I 
observed marginal increases in Zhx1 and Zhx3 gene expression in Zhx2ko male kidney. 
The same group demonstrated Zhx proteins were redistributed to the nucleus during 
disease.  
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Although known Zhx2 targets were not altered in Zhx2ko kidney, we cannot rule 
out the possibility that Zhx2 influences progression of kidney disease. A more 
comprehensive study would be needed to test this possibility.  I should note, however, that 
Wt1 and Lmx1b mRNA levels did not change in Zhx2ko kidney.  A change in expression 
of these genes, which are important in kidney development and function [126], would 
justify further studies of Zhx2 and kidney function. If we want to assess the kidney function 
of Zhx2ko mice, we might test podocyte protein-tyrosine phosphatase (GLEPP1) because 
this gene will be decreased when there is defect in the kidney function.  Anasarca is another 
sign of kidney disease when humans or animals accumulate fluid under the skin. This 
phenotype has not been seen in the Zhx2ko mice, presumably, because severe Anasarca rats 
die very early in life [126]. So we might carefully examine Zhx2ko mice in early ages and 
test blood and urine proteins to investigate if they will develop any sign of Anasarca. 
I observed changes in Mup expression in SG and LG; previous studies indicate that 
Mups are regulated by growth hormone [95]. Previous studies from our lab indicated that  
Cyp2a4 is regulated by Zhx2 in the liver [Creasy Thesis, 2015] and by growth hormone 
[124]. Therefore, it seems logical that Stat5 and Cyps could be altered in different tissues 
in Zhx2ko mice. However, for the most part this was not the case. Our data showing Cyp2a4 
expression in the male kidney with a level slightly higher than in female kidney is 
consistent with previous results [148] [121]. In conclusion, expression of Cyp2a4, Stat5a, 
H19, Shp, Mat1a, Mup24, H19 and AFP in the male and female kidney did not change in 
the absence of Zhx2. I did notice a trend in Stat5b in Zhx2ko mice, but this was not 
significant. Since this trend was seen with other genes, it is possible that analysis of more 
mice may reveal significant differences in gene expression in the presence or absence of 
Zhx2.  
I expected to see changes in Mup expression in the brain in the absence of Zhx2.  
While Mups were reduced in Zhx2ko brain samples, these differences were not significant. 
Since Mups influence behavior and previous studies suggest that Zhx2 might influence 
mouse behavior, it might be worthwhile to explore Zhx2 and Mups in the brain in greater 
detail. The expression of Cyp2a4 and Mat1a in the brain were low but not affected by Zhx2.  
Nightly expression of Mat2a in rat pineal gland is 5-6 fold higher than daytime, and rat 
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brain pinealocytes are the major producer of Mat2a mRNA in the brain [149]. Rat kidney 
and pineal gland are the only two organs expressing Mat2a. It may be more appropriate to 
monitor Mat2a in the brain, kidney and the liver during darkness.  
We did not observe any changes in Zhx2 target genes in the small intestine of 
Zhx2ko mice. We were particularly interested in Mcpt2 since this gene is expressed 
differently in BALB/cJ mice, but we did not observe changes in Mcpt2 expression in small 
intestine between Zhx2ko and Zhx2wt mice [144].  It might be worthwhile to stain the small 
intestine with mast cell markers to test if the induction of mast cells was altered in the 
presence or absence of Zhx2. My findings that Mat1a is expressed at high levels in the liver 
and very low in the kidney, brain and small intestine is consistent with previous studies 
[34]. My finding that Cyp2a4 is expressed at very low levels in the SI is also consistent 
with previous reports in human and mice [121]. 
In conclusion, I have evaluated expression of Zhx genes and a number of candidate 
Zhx2 genes in various tissues of Zhx2wt and Zhx2ko mice.  We did observe some significant 
changes in Mup expression in SG and LG of Zhx2ko mice. However, for the most part, 
many Zhx2 targets were not altered in organs of Zhx2ko mice, although trends were noted 
for many genes.  It is possible that analysis of a greater number of animals may be needed 
for differences to reach significance.  Even if the data are not significant, this does not rule 
out the possibility that changes in Zhx2 might influence disease processes in various 
models of tissue damage.  It is also interesting that Zhx1 and Zhx3 are normally expressed 
at higher levels than Zhx2 in most tissues. This might explain why we did not see 
compensatory changes in expression of Zhx1 and Zhx3 in Zhx2ko mice. These data raise 
the possibility that Zhx1 and Zhx3 might be important for the development and function 
of different organs. To test these possibilities, more studies will be needed. My data has 
revealed new insight into potential role of Zhx2 in different organs are provide the 
framework for future studies.  
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Figure 3.1 Hepatic Zhx2 mRNA levels are reduced and AFP and H19 
mRNA levels are increased in the livers of Zhx2ko mice. RT-qPCR was 
used to analyze total liver mRNAs from Zhx2wt n=3 and Zhx2ko mice n=3 
cohorts. Zhx2 is dramatically reduced in the Zhx2ko cohort (p=0.0001). 
AFP and H19 were elevated in adult mice Zhx2ko. Data shown are relative 
to L30. *p≤0.05, ***p ≤0.0001. 
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Figure 3.2 Zhx1 is ubiquitously expressed in adults Zhx2wt mice.  Zhx1 is 
highly expressed in the male adult mice kidney (K) as compared to the small 
intestine (SI), salivary glands (SG) and lacrimal gland (LG) (A).  Females SI 
exhibited higher Zhx1 expression as compared to kidney and SG (B). Zhx1 
expression in the SI exhibited females-biased expression.  Data shown are 
relative to L30. Each Colum represents 3 mice. ** p≤ 0.001. 
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Figure 3.3 The highest Zhx2 mRNA levels are found in male kidney 
and female small intestine of adult Zhx2wt mice. RT-qPCR was used 
to analyze Zhx2 expression in the kidney, small intestine (SI), liver, brain 
(B), salivary (SG) and (LG) lacrimal glands of males Zhx2wt mice with 
the highest expression detected in the kidney (A). In female mice, the 
highest Zhx2 levels  were found in the SI (B). Although not statistically 
significant, higher Zhx2 expression was found in the SI of female mice 
and the kidney of male mice (C). Data shown are relative to L30. Each 
Colum represents 3 mice. Tukey’s analysis was employed to perform 
multifunctional analysis. 
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Figure 3.4 Zhx3 mRNA is expressed at equal levels in male and 
female Zhx2wt kidney and SI. RT-qPCR was used to analyze Zhx3 
expression in multiple male and female mice organs. Male kidney RNA 
levels are higher than other organs (A). In female mice, Zhx3 is expressed 
at higher levels in kidney than the SI (B). There is no sex difference in 
Zhx3 expression in the kidneys or SI (C). Data shown are relative to L30. 
Each Colum represents 3 mice. 
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Figure 3.5 Zhx2 and Zhx2 targets are properly regulated 
in BALB/c and BALB/cByJ mice. Adult liver RNA from 
BALB/c, BALB/cJ and BALB/cByJ mice was analyzed by 
RT-qPCR. Data indicate that Zhx2 expression was reduced, 
while AFP and H19 mRNA levels were elevated in BALB/cJ 
mice compared to the closely related strains BALB/c and 
BALB/cByJ. MUP24 expression was reduced in BALB/cJ 
liver, consistent with it being positively regulated by Zhx2. 
Data shown are relative to L30. Each Colum represent 2 mice. 
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Figure 3.6 Expression of Mup genes are inversely correlated with 
Zhx2 expression in male SG. Total RNA from adult male Zhx2wt and 
Zhx2ko SG was analyzed by RT-qPCR Mup18, Mup 24, and class B Mups 
(MupU) were significantly increased in the absence of Zhx2; Mup1 also 
increased but this difference was not significant. Mup25 levels showed 
no change. Data shown are relative to L30. Each Colum represents 6 
mice. *p≤0.05, ****p≤0.0001. 
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Figure 3.7 Mup1 and Mup18 are regulated by Zhx2 in female SG. 
SGs RNA was examined by RT-qPCR to quantify the difference between 
Zhx2
wt
 and Zhx2
ko
 littermates. Mup1 and Mup18 are significantly 
decreased in Zhx2
ko
 mice whereas Mup24 and Mup25 are the same in 
both groups. Data shown are relative to L30. Each column represents 6 
mice. * ≤0.05; ****p≤0.0001. 
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Figure 3.8 The lack of SG sexual dimorphism of MUP1 and MUP18, 
MUP24 and MUP25 expression. Analysis using RT-qPCR of SG mRNA 
of males and females demonstrated that Mups are expressed in 
comparable levels in both sexes. Data shown are relative to L30. Each 
Column represents 6 mice. 
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Figure 3.9 The absence of Zhx2 does not alter Zhx1, Zhx3 or H19 
levels in male SG. RNA was examined by RT-qPCR to quantify 
differences between Zhx2
wt
 and Zhx2
ko
 littermate. Zhx1, Zhx3 and H19 
did not exhibit significant changes when Zhx2 was absent. Zhx1 and 
Zhx3 are expressed at higher levels than Zhx2 in the female SG. Data 
shown are relative to L30. Each Colum represents 6 mice. ****p≤0.0001. 
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Figure 3.10 The absence of Zhx2 does not alter Zhx1, Zhx3 
or H19 levels in female SG. RNA was examined by RT-qPCR 
to quantify differences between Zhx2
wt
 and Zhx2
ko
 littermate. 
Zhx1, Zhx3 and H19 did not exhibit significant changes when 
Zhx2 was absent. Zhx1 and Zhx3 are expressed at higher levels 
than Zhx2 in the female SG. Data shown are relative to L30. 
Each column represents 6 mice. ****p≤0.0001. 
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Figure 3.11 Expression of Mups are not altered in the absence of 
Zhx2 in male LG. Analysis by RT-qPCR indicated that LG Zhx2 
mRNA levels decreased dramatically in Zhx2
ko
 mice. While Mup1 
and class B Mup mRNA levels increased in the absence of Zhx2, 
these differences were not significant. Zhx1 and Zhx3 mRNA levels 
were not altered in male Zhx2
ko
 LGs. Data shown are relative to L30. 
Each Column represents 3 mice. 
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Figure 3.12 MUP1 is the most abundant Mup in LG 
whereas Mup18 is the most abundant Mup in SG, as 
determined by RT-qPCR. Data shown are relative to L30. 
Each Column represents 3 mice. 
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Figure 3.13 Expression of several Mup genes is not altered 
in liver of male Zhx2ko mice. Expression of Mups was analyzed 
by RT-qPCR. Class B Mups (MupU), Mup24, Mup25 and 
Mup26 are expressed at high levels in male liver.  As expected, 
Mup1 and Mup18, which are expressed in SG and LG, are 
expressed at very low levels in the liver. None of these Mups 
appear to be regulated by Zhx2. Data shown are relative to L30. 
Each Column represents 3 mice. 
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Figure 3.14 Mat1a levels decrease in adult liver of male Zhx2ko 
mice. Cyp2a4, Stat5a, Stat5b, Shp, Emr1, or Hnf4α levels were not 
significantly different between Zhx2wt and Zhx2ko livers. Mat1a 
RNA expression is significantly reduced in Zhx2
ko
 male mice liver. 
Data shown are relative to L30. Each Column represents 3 mice. 
*p≤0.05 
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Figure 3.15 Mup24 mRNA levels are reduced in adult female liver in 
Zhx2ko mice. MUP24, but not Mup1 Mup18, or class B Mups, was 
significantly decreased in Zhx2
ko
 mice (A).  Mup 24 and class B Mups 
are expressed at higher level in male liver than in female liver. (B). Data 
shown are relative to L30. Each Column represents 3 mice. 
 *p≤0.05. 
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Figure 3.16 Zhx2 regulates Mat1a in the female mice liver.  
Expression of Cyp2a4, Stat5a, Stat5b, Mat1a and Shp were analyzed 
in the total RNA of female mice liver using RT-qPCR. Mat1a, but 
none of the other genes tested, changed in the absence of Zhx2. Data 
shown are relative to L30. Each Column represents 3 mice. *p=0.01. 
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Figure 3.17 Expression of Zhx2 and candidate Zhx2 target genes in 
the male kidney. Zhx2 is expressed in the kidney but at levels that are 
lower than Zhx1 and Zhx3.  The kidney genes Wt1 and Lmx1b are not 
altered in the absence of Zhx2. A number of other genes, including several 
that are known to be regulated by Zhx2 in the liver, are not altered in the 
absence of Zhx2 in the kidney. Data shown are relative to L30. Each 
Column represents 3 mice. ** p≤0.005. 
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Figure 3.18 A positive trend was observed between Zhx2 and Stat5b 
in the females’ kidney. RT-qPCR analysis of female adult kidney 
indicates that candidate Zhx2 target genes are not altered in the absence 
of Zhx2. Stat5b showed a modest decline in Zhx2ko kidneys but this was 
not significant (A). Although, Cyp2a4 is female-biased in the liver, 
Cyp2a4 levels in the kidney are comparable between male and female 
(B). Data shown are relative to L30. Each Column represents 3 mice. *** 
p≤ 0.001. 
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Figure 3.19 Candidate Zhx2 target genes are not altered in adult male 
Zhx2ko brain. Total adult male mouse brain mRNAs were analyzed by 
RT-qPCR. Although Zhx2 was dramatically reduced in knock-out mice, 
none of the other genes tested exhibited a significant change. Data shown 
are relative to L30. Each Column represents 3 mice. ****p≤0.0001.  
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Figure 3.20: Candidate Zhx2 target genes are not altered in adult 
female Zhx2ko brain. Total adult female mouse brain mRNAs were 
analyzed by RT-qPCR. Although Zhx2 was dramatically reduced in 
knock-out mice, none of the other genes tested exhibited a significant 
change. Data shown are relative to L30. Each Column represents 3 mice. 
****p≤0.0001.  
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Figure 3.21 Zhx2 target gene expression is not altered in adult male 
Zhx2ko small intestine. RT-qPCR of total RNA of males SI of Zhx2, 
Zhx1, Zhx3 and Zhx2 target genes is shown. Data shown are relative to 
L30. Each Column represents 3 mice.****p≤0.0001.  
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Figure 3.22 Zhx2 target gene expression is not altered in adult female 
Zhx2ko small intestine. RT-qPCR of total RNA of males SI of Zhx2, 
Zhx1, Zhx3 and Zhx2 target genes is shown. Data shown are relative to 
L30. Each Column represents 3 mice. *p≤0.05.  
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CHAPTER 4 
The effect of Zhx2 in postnatal mouse survival 
Introduction 
Embryonic and postnatal lethality is often seen in knock-out mice. We have 
observed viable Zhx2 knock-out mice, so we know that the absence of Zhx2 is compatible 
with life. However, it seemed that postnatal survival of Zhxko mice might be decreased.  
Therefore, I performed a careful analysis of postnatal survival and body weight increase of 
mice that are wild-type, heterozygous or homozygous for deleted Zhx2 allele. 
Results: 
Postnatal survival of male Zhx2ko mice is reduced: 
Matings were set up between mice that were heterozygous for the Zhx2 allele 
(Zhx2+/-). Cages were monitored carefully to identify litters on the day that they were to 
be born. Mice were monitored for two months, at which time they were euthanized and 
DNA was prepared. I also prepared DNA from any mice that died during the two months 
period. I calculated the number of mice at birth, postnatal day 13 (p13), p20, p33, p44 p50 
and p60. I then calculated the percentage of Zhx2+/+ (Zhx2wt), Zhx2+/- (Zhx2het) and 
Zhx2-/- (Zhx2ko) mice [Data not shown]. Of the three mice cohorts in the study at day 60, 
we expected to get 25% Zhx2ko, 25% Zhx2wt and 50% Zhx2het mice according to Mendelian 
principles. At p60, the number of surviving male Zhx2ko mice was reduced to 15.9%, which 
is 9.1% less than expected (Table 4.1). These data suggest that postnatal death of Zhx2ko 
mice occurs in males but not females. 
Weekly measurement indicated a comparable weight gain of Zhx2wt, Zhx2het and 
Zhx2ko mice cohorts which have been fed normal diet (ND): 
Previous studies indicated that BALB/cJ mice gained more weight than BALB/c 
and BALB/cJ+Zhx2 over an eight weeks period when maintained on a high-fat diet. 
[Clinkenbeard Thesis, 2012]. I therefore weighed the male and female Zhx2wt, Zhx2het and 
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Zhx2ko over a 60 day period when maintained on a regular chow diet. All three female 
cohorts of mice exhibited the same weight gain (Figure 4.1B). However, multiple 
comparison analysis using Tukey’s test showed significant differences between males 
Zhx2ko and both Zhx2wt and Zhx2het on day 33 only (Figure 4.1A). This difference is 
transient as all three male cohorts had the same weight after this one time point.  
Overall, there was no significant correlation between knocking down Zhx2, the 
mice survival rate and gaining weight. Although not significant, there was a trend in the 
direction of a negative correlation between those parameters.   
  
Discussion 
 In this project, we monitored survival and postnatal weight gain in Zhx2wt, Zhx2het 
and Zhx2ko. These data indicate that male Zhx2ko are born at a lower percentage than 
predicted, although female are born at the expected ratio. We saw no differences in weight 
gain in female mice, but did observe that male Zhx2ko mice exhibited lower weight at p33 
compare to Zhx2wt and Zhx2het littermates.  
Our thinking about increased death in genetically modified mice is logical since 
similar observation has been reported in the literature and it is due to numerous reasons 
such as disturbance in neonatal physiological functions including respiratory system, 
malnutrition and homeostasis [150]. In this Chapter, our data have demonstrated that male 
Zhx2ko mice were compromised 15.9% of the total live males’ mice in this study. 
Interestingly, the percentage was less than our expectation of 25%. These findings support 
our previous lab observation and it is novel by being in males only, suggesting that the 
presence of Zhx2 could play a role in producing healthy pups, however, one cannot be 
certain if there are other factors have participated in this phenotype. Although, the majority 
of dying pups after birth were Zhx2ko (data not shown), we have not genotyped the newly 
born pups to verify their sexes. We believed that the new dying pups are mostly males. 
Further investigations are required to elucidate these findings (Project is continued).   
73 
 
The study period for this project was 6 months and through this time we noticed 
that 5 dwarf mice had short necks in addition to being developmentally delayed. Three of 
them were Zhx2ko and two were Zhx2het, they comprised 5% of the total number of the off 
spring. Interestingly, we have not seen dwarf Zhx2wt mice. Therefore, given that Zhx2 
regulates Stat5a and Stat5b [Creasy Thesis, 2015], and Stat5 is critical regulator of growth 
hormone [146], Mups are downregulated in little mice as well as growth hormone [96], 
and Zhx2 regulate Mups (Previously discussed in Chapter 3), we hypothesized that 
knocking out Zhx2 may delay mice growth and development through disturbing growth 
hormone. We recommend doing a larger study that spans at least two years. 
On contrast, when we bred male Zhx2ko to female Zhx2ko to examine if knocking 
out Zhx2 could be lethal or would produce health disorders, our visual observations have 
shown normal appearances for 95% of the pups and 5% are dwarf, the rate of weight gain 
was normal as compared to pups which were offspring of Zhx2het male bred to Zhx2het 
female (Data not shown). Although, we need to monitor more mice, this data suggest that 
Zhx2 regulation is likely occurring exclusively in male Zhx2het bred to female Zhx2het mice.  
Moreover, Lusis et al 2009 have identified Zhx2 as a governor of BALB/cJ Hyplip2 
phenotype. [Clinkenbeard Thesis, 2012] has described Zhx2 as a natural hepatic guardian 
against lipid accumulation. Zhx2 is a regulator of several lipid metabolism genes which 
might play a role in CVD [Creasy Thesis, 2015]. For all these reasons, we speculate and 
correlate Zhx2 to cardiovascular disease and weight gain. In fact, genetic factors have an 
important role in CVD and NAFLD, although, they are governed by many other factors 
such as food intake, physical activity, smoking, age and environmental. Considering the 
fact that one of seven deaths caused by coronary heart disease [151], if knocking out Zhx2 
could increase mice susceptibility to weight gain, Zhx2 might be an alternative treatment 
option to promote survival.     
All these data led us to logically propose that Zhx2ko are more susceptible to weight 
gain than Zhx2wt mice. Unexpectedly, our observation has shown that differences in weight 
gain rates between Zhx2wt, Zhx2het and Zhx2ko were not significant, even though, we 
observed only a slight decrease in weight of few male and female Zhx2ko as compared to 
Zhx2wt and Zhx2het on day (D)13. Tukey’s test has detected significant differences in 
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gaining weight of male mice on day 33 might be due to the deletion of Zhx2 and the need 
has been compensated on the following time period due to elevated expression of unknown 
developmental genes, it could be another Zhx family member or similar function genes. 
The fact that small females have gained more weight when they are adults could be because 
female hormones are likely to make them gain more weight than males. In support of this 
hypothesis, it has been reported that women tend to gain more weight than males due to 
hormonal and biological differences [152]. I suggest for future studies to place mice on 
high fat diet and track the weekly measurement of weight gain (Discussed in Chapter 6).  
Newborn mice mortality associated with mice genotypes remain substantial, 
although evidence of sex-related differences in mortality remain equivocal. Results in 
Chapter 3 revealed regulation of Zhx2 to several salivary glands MUPs, Mice mother 
behavior will be influenced due to excess or less Mups being secreted into the mice 
environment, where they activate neuronal sensors in the nasal cavity. This data led us to 
speculate that Zhx2het and Zhx2ko pups can miss communicate with their mothers if they 
expressed different levels of Mups proteins (Discussed in details in Chapter 3), and perhaps 
could be partially neglected by their parents. 
 In summary, in this project we presented that Zhx2 correlates with early pup’s 
death. Based on our visual observation, we noticed a trend towards positive correlation 
between the dwarf mice and having heterozygous or knock out Zhx2 status. Finally, we 
found no significant correlation between Zhx2 and mouse susceptibility to gain weight 
except in males on day 33. 
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Table 4.1 Mice survival at p60 
Breeding 
Cycles 
Males Females 
Zhx2wt Zhx2het Zhx2ko Zhx2wt Zhx2het Zhx2ko 
#1 0 4 1 2 2 1 
#2 1 3 0 2 4 1 
#3 1 2 1 0 1 1 
#4 1 2 1 0 1 2 
#5 3 11 3 4 8 5 
#6 2 1 0 2 2 0 
#7 2 0 0 1 1 0 
#8 0 1 1 0 4 1 
#9 1 2 0 0 0 5 
Total 94 11 26 7 11 23 16 
Mice % 25% 59% 15.9% 22% 46%
  
32% 
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Figure 4.1 Comparable weight gain rates were observed in Zhx2wt, 
Zhx2het and Zhx2ko males and female mice cohorts. Males (A) and 
females (B) were placed on normal diet for 8 weeks and weekly weight 
measurements have indicated no significant correlation with Zhx2 
genetic background of the mice groups except Zhx2
ko
 males on day 33 
has shown reduction in gaining weight as compared to the Zhx2
wt
 and 
Zhx2
het
.  Males Zhx2
wt
 n=10, Zhx2
het
 n=10, Zhx2
ko
 n=7, female Zhx2
wt
 
n=9, Zhx2
het
 n=10, Zhx2
ko
 n=7 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Minen Al-Kafajy 2016 
 
78 
 
Chapter 5  
Zinc finger and homeoboxes (Zhx (family members Zhx1, Zhx2 and Zhx3)): 
subcellular localization and predicted structural models 
Introduction  
 Proper cell physiological functions require proper protein localization and 
trafficking. Aberrant protein site between the nucleus and the cytoplasm might result in 
aberrant cell signaling, which could contribute to numerous health disorders such as 
cardiovascular disease [153], kidney pathogenesis [126], and cancer [65]. Targeting 
aberrantly localized proteins has been employed in designing human therapies [153].  
Several previous studies have investigated Zhx protein binding affinity and their 
localization in different cell compartments. For instance, transfected human ZHX1-GFP 
localized to the nucleus in HEK293 cells [52] and similar results have been reported when 
the same cell line was transfected with rat ZHX1-GFP [47, 154]. Human ZHX3 can be 
homodimerized or heterodimerized with ZHX1, ZHX2, NF-YA and localized primarily to 
nuclei in HEK293 cells [47]. However, different results have been obtained in rodent 
kidney, including models of kidney disease.  In these studies, it appears that ZHX1, ZHX2 
and ZHX3 exist as cytoplasmic heterodimers in normal rat kidney podocytes with 80%, 
95% and 95%, respectively. In the incidence of kidney Puromycin nephrosis disease, ZHX 
proteins lose their dimerization and the majority of ZHX3 translocates to the nuclei. 
Transfected rat ZHX3 tagged with V5 into HEK293 cells localizes to the nucleus; these 
have been further confirmed using western blot. In general, ZHX protein localization is 
altered in models of kidney disease, suggesting that these proteins might play a role in 
glomerular diseases and could serve as future potential prognostic markers in patients, 
since translocation from normal cellular location has been correlated with the occurrence 
of the disease [126].  
In an attempt to assess ZHX1 localization, one group transfected a ZHX1 (1-873 
a.a) full length linked to GFP in HEK293 and observed it in the cells nuclei. Truncated 
ZHX1 (469-473 a.a), (741-765 a.a) and (861-867 a.a) having NLS, when fused to GFP all 
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of them have been detected in the nuclei.  In contrast, when Zhx1 Zinc finger domains are 
fused to GFP, this fusion protein is observed in the cytoplasm [52]. The homeodomain 2 
(HD2) region of ZHX1 also has a NLS [47], and this domain may be involved in binding 
NF-YA [45]. Moreover, ZHX1 has been reported to bind several other proteins including 
the BS69 co-repressor, ataxia-telangiectasia-like protein, Androgen-induced aldose 
reductase, ATP-IP, Spinocerebellar ataxia type I, Zyxin, Elf-1, and Eleven-nineteen lysine-
rich leukemia gene[47]. The ZHX1 core amino acid sequences are conserved between 
humans and mice despite differences that have been seen in both the C- and N- terminal 
ends [50]. The rat ZHX1 protein is also conserved, with 92.6% similarity with human and 
96.7% with mice [154]. Furthermore, ZHX1 is unique by having 2 NLS, one in the 740-
860 a.a region and a second in the C-terminal 830-851 a.a. region [50]. 
ZHX2 is localized to the nucleus in normal human but is often found in the 
cytoplasm in HCC. Interestingly, in HCC patients, higher cytoplasmic and decreased 
nuclear ZHX2 correlates with poor prognosis and decreased overall survival rate. This may 
be due to enhanced HCC cell proliferation and increased tumor microvascularization. 
ZHX2 expression plasmids injected into HCC tumor or transfected into cancer cell lines 
reduced tumor growth and cell proliferation, respectively. Surprisingly, ZHX2 has to reside 
in the nucleus in order to halt HCC proliferation in vitro and in vivo experiments. In 
conclusion, liver ZHX2 localization can be employed as a potential prognostic HCC 
marker, or it could serve as a target for HCC treatment  [65]. ZHX2 has two or more NLS, 
since the full length ZHX2 (1-873 a.a) and truncated forms (1-262 a.a), (263-497 a.a), (263-
446 a.a) and (317-446 a.a) tagged with GFP exhibit nuclear localization in HEK293 cells. 
In contrast, other truncated forms of ZHX2 (317-407 a.a), (408-440 a.a) (441-783) fused 
to GFP do not localize to the nucleus [46]. Curiously, ZHX2 localization in the brain was 
different than what has been observed in the liver and HEK-293 cells, but similar to the 
kidney, since it has been observed in the cytoplasm where it has been shown to bind to the 
cytoplasmic domain of ephrin-B1 in neuronal progenitor cells (See Chapter 1 for details). 
Zhx2 cytoplasmic localization appears to be crucial for halting neuronal cell 
differentiation. However, Ds Red-tagged Zhx2, localized to the nucleus in transfected 
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COS-7 cells [76]. ZHX2 contains a proline rich region that might enhance its binding 
affinity [46], and ZHX2 has been reported to bind NF-YA [46]. 
To investigate which part of ZHX3 determines its cellular localization, HEK293 
cells transfected with full-length rat ZHX3 (1-956 amino acids (a.a)) fused to GFP was 
detected solely in the nucleus. A series of truncated forms of ZHX3 were then generated 
and each showed different cellular localization. For example, ZHX3(1-303)-GFP and 
ZHX3(303-555)-GFP where observed in the nucleus, suggesting that ZHX3 contains two 
or more nuclear localization signals (NLS). However, ZHX3 (555-956)-GFP localized to 
the cytoplasm, indicating that this region lacks a NLS or contains nuclear export signal 
(NES). Moreover, ZHX3(242-488) has been hypothesized to bind ZHX1 while ZHX1 
(272-432) containing HD1 and HD2 can homodimerize or heterodimerize with ZHX3 [47]. 
NF-YA binds to ZHX3 via HD1 [47]. 
These findings support the idea that ZHX proteins are transcription factors and their 
nuclear location is pivotal for their function. All Zhx proteins have two ZFs and 4 or 5 
HDs; ZHX3 also possesses a glutamic acid-rich region located between a.a. 670-710; this 
is often involved in DNA binding [47].  While more studies are needed, it appears as though 
ZHX protein localization can be determined by cell type, disease state and species. Due to 
the notion that different ZHX proteins can possibly bind different targets, and the fact that 
different cell line might express different proteins, I decided to use bioinformatics tools to 
find predicted ZHX-interacting proteins. 
Bioinformatics 
Little is known about Zhx interacting proteins and Zhx tertiary structure. This 
necessitates efforts to predict the tertiary structure of Zhx proteins in order to reveal 
possible Zhx-interacting proteins. The iterative threating assembly refinement (I-TASSER) 
is a computational website described in Nature journal as a reliable method in using 
sequence, structure and function standards to predict protein tertiary structure and function. 
This method is based on similarity between the predicted structure and the structure of 
well-known proteins, since it is reasonable to believe that similarity in structure will reflect 
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similarity in function. Another reason to choose I-TASSER is that it is rated as one of the 
best automated method in predicting protein structure by CASP (Community-wide critical 
assessment protein structure prediction) [155]. Moreover, I-TASSER has TM-align 
function that will align the target protein sequence to all proteins in the protein data base 
(PDB) library and find 10 proteins which have shown high homology to the target gene. I-
TASSER, through its COACH function, can predict the top 5 proteins that might have 
affinity to bind target proteins, anticipate the residues that might be involved in the binding 
and in some cases they provide 3D simulation of the binding [114]. Protein-protein 
interactions within cells mediate cell signaling pathways that are vital for cell function. 
Interestingly, the ZDOCK protein-protein docking algorithm server is the highest-
resolution computational method which can be used to predict the likelihood that two or 
more proteins might bind together and identify which domain might be responsible for the 
proposed binding. M-ZDOCK, another server in ZDOCK website, analyzes the likelihood 
that target protein can form dimer or trimer with 3D simulation of the final structure  ]115[ .  
In summary, ZHX protein localization changes have correlated to numerous 
diseases and there are conflicting data reporting ZHX protein localization. Therefore, in 
this Chapter I have investigated ZHX localization in transfected HEK293 cells and primary 
mouse hepatocytes and have analyzed ZHX structures using bioinformatics tools. These 
studies could further define the molecular and cellular localization of ZHX proteins and 
reveal possible binding partners, thus providing information for future clinical targeting of 
Zhx proteins for therapeutic use. 
Results 
In this Chapter, I describe localization and predicted biological properties of mouse 
Zhx1, Zhx2 and Zhx3 (Zhx). In previous studies, our lab along with our collaborator data 
have demonstrated that ZHX2 is localized in the liver nuclei [65]. Expression vectors for 
Zhx1, Zhx2 and Zhx3, alone or fused to GFP, were generated. These constructs were 
transfected alone or in combination in primary mouse hepatocytes, Hep3B cells, HeLa cells 
and HEK293 cells. Fluorescence imaging of cells, along with 4’, 6-diamidino-2-
Phenylindale (DAPI) staining of nuclei, was used to determine cellular localization. I 
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observed that GFP alone localized to the cytoplasm in primary hepatocytes cells (Figure 
5.1 A), HEK293 cells (Figure 5.2 A) and HeLa cells (Figure 5.2 B). Similar results were 
seen in Hep3B (data not shown). Zhx1-GFP was detected in the nuclei of primary 
hepatocytes (Figure 5.1 B) and co-localized with DAPI in HEK293, although some of these 
cells exhibited light green fluorescence in the cytoplasm around the nucleus (Figure 5.3 
A). Similar results were seen in Hep3B and HeLa cells (data not shown). Zhx2-GFP was 
highly restricted to the nuclei as all the positive green fluorescent was observed in nuclei 
of the mouse primary hepatocytes (Figure 5.1 C), co-localized with DAPI in HEK293 
(Figure 5.3 B), and in the nuclei of Hep3B and HeLa cells (data not shown). Curiously, all 
the Zhx3-GFP were observed in the entire cells of primary hepatocytes (Figure 5.1 D) and 
similar results were seen in HEK293 (Figure 5.3 C), Hep3B and HeLa cells (data not 
shown). Black dots in the nuclei indicate that Zhx1, Zhx2 and Zhx3 are absent from the 
nucleolus (Figure 5.3 A-C). 
In conclusion, Zhx1-GFP and Zhx2-GFP are localized to the nuclei, while Zhx3-
GFP is found throughout the entire cell of transfected primary hepatocytes, HepG2, HeLa 
cells and HEK293 cells. 
Investigate the possibility that Zhx proteins could influence each other localization 
Several groups have reported that ZHX proteins can form heterodimers [46, 47, 
156]. In an attempt to assess Zhx proteins binding affinity and how the Zhx family members 
could impact each other subcellular localization, HEK293 cells were co-transfected with 
Zhx1 or 2 or 3 linked to GFP with Zhx1or 2 or 3 linked to hemagglutinin (HA).  
Zhx1-GFP localization is slightly altered when co-transfected with Zhx3-HA 
First, HEK293 cells were transfected with Zhx1-GFP plus Zhx1-HA as ZHX1 has 
been reported to form a homodimer [47]. We found that the majority of positive green cells 
were localized in the nucleus (Figure 5.4 B). Since ZHX1 has been proposed to bind ZHX2 
[156], we investigated whether Zhx2 could alter Zhx1-GFP localization. Therefore, we co-
transfected Zhx1-GFP with Zhx2-HA in HEK293 and in all cases, I observed GFP in the 
nucleus and therefore did not observe any deviations in Zhx1-GFP nuclei localization 
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(Figure 5.4 C). To determine if Zhx3 might alter Zhx1 nuclear position and since ZHX1 
has been proposed to form heterodimer with ZHX3 [47], we co-transfected Zhx1-GFP with 
Zhx3-HA. We observed that a majority of the cells exhibited nuclear GFP except two cells 
also showed cytoplasmic staining localization (Figure 5.4 D). 
Zhx2-GFP localization is not altered by co-transfection with Zhx1-HA, Zhx2-HA or 
Zhx3-HA 
In order to assess if Zhx2-GFP nuclear localization can be altered by Zhx1, we 
performed co-transfection of Zhx2-GFP with Zhx1-HA in HEK293 cells. In these co-
transfections, Zhx2-GFP always localized to the nuclei (Figure 5.5 B), indicating that 
Zhx2-GFP localization was not altered by Zhx1-HA. Similarly, when Zhx2-GFP was 
cotransfected with Zhx2-HA or Zhx3-HA, Zhx2-GFP maintained its nuclear localization 
(Figure 5.5 C and Figure 5.5D, respectively).  
Zhx3-GFP localization was altered by co-transfection with Zhx2-HA, but not by 
Zhx1-HA or Zhx3-HA 
 Zhx3-GFP, in HEK293, is found in both the nucleus and cytoplasm. (Figure 5.3 C 
and 5.6 A). In order to investigate whether other Zhx family members can influence Zhx3-
GFP cellular localization, I co-transfected Zhx3-GFP with Zhx1-HA, since Zhx1 has been 
reported to bind ZHX3 [47]. All the green fluorescence was found in nucleus and 
cytoplasm in cotransfected cells, indicating that Zhx1 did not influence Zhx3 localization. 
When Zhx3-GFP was co-transfected with Zhx2-HA, we noticed that green fluorescence 
was localized to the nucleus in HEK293 cells (Figure 5.6 C) and Hela cells (data not 
shown). When Zhx3-GFP was co-transfected with Zhx3-HA in HEK293 cells, GFP 
staining was found in cytoplasm and nucleus (Figure 5.6 D). These data indicate that Zhx2 
can alter localization of Zhx3 to the nucleus. 
Bioinformatics prediction of mouse Zhx1, Zhx2 and Zhx3 tertiary structure as 
monomers, homodimers and heterodimers and identification of domains predicted to 
be involved in the binding 
84 
 
The fact that Zhx3-GFP was localized to the nucleus after co-transfection with 
Zhx2-HA, along with previous Zhx protein localization data in the literature, led me to use 
a bioinformatics approach to investigate Zhx protein structures. The I-TASSER prediction 
website [114] was used to predict Zhx family tertiary structures, and PyMOL software was 
used to visualize the predicted models (The PyMOL Molecular Graphics System, Version 
1.8 Schrödinger, LLC). The highest scored three dimensional (3D) models of Zhx1, Zhx2 
and Zhx3 are shown in (Figure 5.7 A-C). I-TASSER also predicted possible proteins that 
the Zhx family can bind with scores ranked from highest to lowest (data not shown). To 
identify Zhx protein domains that may be responsible for homodimerization and 
heterodimerization with each other, ZDOCK was used to predict the binding domains 
between ZHX proteins.  I also used M-ZDOCK to predict the 3D structure of ZHX protein 
homodimers (Figure 5.8 A-C) and heterodimers (Figure5.9 A-C). 
http://zhanglab.ccmb.med.umich.edu/I-TASSER/ 
Prediction of homodimer formation 
 M-ZDOCK predicts that Zhx1 can form homodimer when ZF1, ZF2 and HD4 of 
one Zhx1 molecule binds HD1 and HD2 of the other Zhx1 molecule. Moreover, Zhx1 HD5, 
which is known to be acidic and has higher affinity for binding, has been predicted to be 
involved in forming the Zhx1-Zhx1 homodimer (Figure 5.8 A). Zhx2 is predicted to form 
a homodimer when ZF1 of one Zhx2 molecule binds the HD1 of the other molecule and 
vis versa (Figure 5.8 B). Finally, Zhx3 can form a homodimer through ZF1, ZF2, HD2 and 
HD3 of both Zhx3 molecules (Figure 5.8 C) and (Table 5.1). 
Heterodimer prediction 
 ZDOCK predicted that ZF1 and ZF2 of Zhx1 is required for its interaction with 
ZF1 and ZF2 of Zhx2, while HD2 of Zhx1 can bind with Zhx2 HD4 to form the Zhx1-
Zhx2 heterodimer (Figure 5.9 A).  ZDOCK also predicts that Zhx1 ZF1, HD1, HD2, HD3 
could participate in forming Zhx1-Zhx3 heterodimer via docking with ZF1, ZF2, HD1, 
HD2 and HD3 of Zhx3 (Figure 5.9 B).  Finally, Zhx2 HD1, HD2, and HD4 have been 
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predicted to bind Zhx3 HD1, HD3 and HD4. Interestingly, Zhx3 Zn1, Zn2 and HD5 are 
not predicted to be involved in binding (Figure 5.9 C) and (Table 5.1).  
Discussion 
In this Chapter, I reported data regarding Zhx protein localization in different cell 
lines and mouse primary hepatocytes by use of GFP fusion proteins. This is an ongoing 
study. Although, the majority of data generated by our lab, our collaborators or 
independents groups that have discussed the functions and localization of Zhx family are 
still preliminary, this report provides the initial efforts to monitor the role of protein-protein 
interactions in understanding Zhx protein localization.  
We expected GFP, when tested alone, to be distributed throughout the cells as has 
been seen in previous studies in HEK293 cells [52].  Our data has indicated that Zhx1-GFP 
and Zhx2-GFP are localized in the nucleus is not surprising, since similar data with rat 
proteins have been reported in previous publications [46] [156]. However, our data are 
novel since we are the first to transfect mouse Zhx proteins and this is the first evidence 
that mouse Zhx3 is distributed throughout the entire cell, since previous literature indicated 
that ZHX3 is localized in the nucleus only [47, 53], although my data is similar to rat kidney 
ZHX3 tissue immunofluorescent staining [126].  It is possible that the GFP in our hybrid 
GFP-Zhx3 is altering Zhx3 localization.  We fused GFP to the N-terminal side of Zhx3, 
whereas others fused GFP to the C-terminal side of Zhx3 might account for the different 
results. 
  The fact that Zhx1 and Zhx2 reside in the nucleus is consistent with their predicted 
function as transcription factors that bind to the promoter region of target genes to repress 
or enhance transcription [43, 48]. This hypothesis is supported by studies in our lab and 
others. The presence of cytoplasmic Zhx3-GFP raises the possibility that Zhx3 might have 
cytoplasmic functions.  Zhx3 has also been proposed to be transcription factor, so we might 
predict that Zhx3 could shuttle between the nucleus and the cytoplasm and possibly shuttle 
other proteins with it. 
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Even though my study is preliminary, we have discussed these results with Dr. 
Martha Peterson (personal communication) and feel that further studies are justified, 
particularly since Zhx2 localization appears to be altered in HCC. Current studies being 
carried out by others are using Zhx proteins fused to fluorescent tagged (mCherry and 
Tomato). Studies with these will help co-localize Zhx proteins. We are also using confocal 
microscopy to better image transfected cells.   
The fact that Zhx2-GFP to be strictly exists in the nuclei after co-transfection with 
Zhx1-HA, Zhx2-HA and Zhx3-HA could have two explanations. First, Zhx2-GFP might 
not bind Zhx1-HA or Zhx3-HA, and the second that there is a binding that is not 
influencing Zhx proteins normal localization. In general, the binding of our Zhx proteins 
is still largely elusive.   
When we compare Zhx1-GFP and Zhx2-GFP nuclear localization, we see that 
Zhx1-GFP covers a larger nuclear area than Zhx2-GFP and some of the Zhx1-GFP 
transfected cells exhibit light green fluorescence in the perinuclear region. These might be 
explained by at least some Zhx1-GFP being present in the cytoplasm region just around 
the nucleus. It is not clear whether this means that Zhx1 can shuttle back and forth from 
the nucleus to the cytoplasm or if such shuttling might be functionally significant. We 
might speculate that Zhx1 could bind proteins present in the cytoplasm, since it has been 
hypothesized that Zhx1 binds the co-repressor BS69 [47], which is a nuclear protein but 
has a cytoplasmic domain and binds target in the cytoplasm [157]. The Yeast two-hybrid 
system showed that Zyxin could bind ZHX1[47]. Interestingly, Zyxin is a trafficking 
phosphoprotein that resides mainly in the integrin-rich cytoplasmic area and transport 
proteins between the nucleus and the cytoplasm and vice versa [158]. 
The fact that Zhx3-GFP cellular localization has not been altered after Zhx1-GFP 
co-transfection suggest that that Zhx3-GFP might not bind Zhx1-HA or that such binding 
is insufficient to move Zhx3-GFP to the nucleus. Staining for HA or repeating the 
transfection with Zhx1 linked to tomato fluorescent might answer this question (project in 
progress). Surprisingly, co-transfection of Zhx2-HA with Zhx3-GFP was able to 
redistribute at least some Zhx3-GFP completely from the cytoplasm to the nucleus. Two 
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potential mechanisms might explain these results; first, consistent with previous studies 
indicating that ZHX2 could bind ZHX3, we hypothesize that a direct binding might occur 
between Zhx3-GFP and Zhx2-HA. The second is that Zhx3 could bind unknown targets in 
the cytoplasm that sequester the Zhx3 NLS. Zhx2-HA could bind to this unknown target 
in the cytoplasm and free Zhx3 to enter the nucleus. This hypothesis is supported by a 
report that found ZHX3 exists as heterodimer in the cytoplasm and upon losing this 
binding, free ZHX3 can translocate to the nucleus.  In contrast to our finding, western blot 
analysis of HEK293 cells transfected with rat ZHX3-V5 has shown ZHX3 localizes mainly 
to the nucleus. Similar results were observed after staining the same cells with anti-V5 
antibody [53]. Different species could account for our different results since we used mouse 
Zhx3 and the other study used rat. There is high homology between human, mice and rat 
Zhx3, but any difference might influence the experiment results. 
 Recruitment of Zhx3 into the nucleus could potentially promote or impede 
transcription of target genes of these proteins in the nucleus. These in vitro studies warrant 
further Zhx1, Zhx2 and Zhx3 localization in various mouse hepatic tissues by 
immunohistochemistry staining. Such studies might provide insight into the function of 
Zhx proteins in different tissues and different diseases 
As can be seen in figure 5.7 A-C, Zhx1 is structurally more similar to Zhx2 than 
Zhx3. This prediction is not surprising since ZHX1 amino acid sequence is also more 
similar to ZHX2 than ZHX3 [156].  Our ZDOCK modelling suggests that HD1 of Zhx1 is 
critical in forming Zhx1 homodimer and heterodimer with Zhx3. Curiously, Yamada et al 
2002 has shown similar results via generating multiple ZHX1 constructs and testing them 
using yeast-two-hybrid system [52]. 
Our docking sites prediction of Zhx binding sites through ZDOCK is consistent 
with Kawata et al [156] by showing that Zhx1-HD1 binds to Zhx3, Zhx1 HD2 binds Zhx2 
and Zhx2 HD1 binds to Zhx3. Moreover, it has been reported that Zhx1 can bind activation 
domain of NF-YA via HD1 and HD2 [45].  ZDOCK predicted that Zhx1 can homodimerize 
via HD1 and heterodimerize with Zhx3 by several domains including HD1 and HD2 
(Figure 5.9 B), which further support the importance of these domains in Zhx1 binding 
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affinity and validate ZDOCK and M-ZDOCK as good programs to predict potential 
interaction domains. On the other hand, Zhx2 HD1 and HD2 have been proposed to be 
important in Zhx2 binding to NF-YA [46]. 
In order to validate ZDOCK and M-ZDOCK predictions, we might prepare a series 
of truncated and mutated Zhx constructs to analyze in tissue culture cells. Of particular 
importance would be NLS and NES regions that are involved in nuclear-cytoplasmic 
localization of Zhx proteins. 
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Table 5.1 Computer prediction of domains participate in forming Zhx homodimer or 
heterodimer 
Binding form First protein  Second protein 
Zhx1-Zhx1 Zhx1 Zhx1 
Computer prediction ZF1 and ZF2 HD1 
HD4 HD2 
 HD5  
Yeast-two-hybrid [52]  HD1 HD1 
Zhx2-Zhx2 Zhx2 Zhx2 
Computer prediction ZF1 HD1 
HD1 ZF1 
Yeast-two-hybrid [46] HD1 HD1 
Zhx3-Zhx3 Zhx3 Zhx3 
Computer prediction ZF1 and ZF2 ZF1 and ZF2 
HD2 HD2 
HD3 HD3 
Yeast-two-hybrid [47] HD1 HD1 
Zhx1-Zhx2 Zhx1 Zhx2 
Computer prediction HD2 HD4 
ZF1 and ZF2 ZF1 and ZF2 
Yeast-two-hybrid [46] HD1 and HD2 HD1 
Zhx1-Zhx3 Zhx1 Zhx3 
Computer prediction ZF1 ZF1 and ZF2 
HD1 HD1 
HD2 HD2 
HD3 HD3 
Yeast-two-hybrid [47] HD1 HD1 
Zhx2-Zhx3 Zhx2 Zhx3 
Computer prediction HD1 HD1 
HD2 HD3 
HD4 HD4 
Yeast-two-hybrid [156] HD1 HD1 
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Figure 5.1 Nuclear localization of Zhx1-GFP, Zhx2-GFP, and cellular 
localization of Zhx3-GFP have been observed in mouse primary 
hepatocytes. Zhx2
wt 
mouse liver was perfused, cells were cultured and 
24 hour later transfected with expression plasmids which encode GFP 
alone, or Zhx1-GFP, Zhx2-GFP or Zhx3-GFP. 48 hours after transfection 
GFP was seen in the entire cell (A), Zhx1-GFP in the nuclei (B). While 
Zhx2-GFP was seen solely in the nuclei (C). Zhx3-GFP was observed in 
both nucleus and the cytoplasm of the cell (D). The left panels are the 
fluorescence microscopy photographs, the middle are the phase contrast 
microscopy photographs of the same fields and the right panels are the 
merge of both pictures. 
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Figure 5.2 Cellular localization of GFP in HEK-293 and HeLa cells. 
GFP plasmid was transfected into either HEK-293 (A) or HeLa cells (B). 
GFP was observed in the entire cell 48 hours after transfection in both 
cell lines. The left panels are the fluorescence microscopy photographs, 
the middle are the phase contrast microscopy photographs of the same 
fields and the right panels are the merge of both pictures. 
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93 
 
 
 
Figure 5.3 Zhx2-GFP and Zhx1-GFP was observed in the nuclei 
while Zhx3-GFP was seen in the entire cell of HEK-293 cells. 
Fluorescent microscopical images have shown Zhx1 (green) localized in 
nucleus with DAPI (blue) and show light green in the cells around the 
nucleus (A). Zhx2 has been seen only in the nuclei (B). Zhx3 (green) has 
overcome the nucleus (blue) in the merge cells and show light blue in the 
nucleus surrounded by green color indicating the presence of Zhx3 in the 
nucleus and the cytoplasm (C). 
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Figure 5.4 Zhx3-HA partially altered Zhx1-GFP localization. 
Fluorescent microscopically images were shown that Zhx1-GFP to 
localize in the nuclei of HEK-293 cells whether it transfected alone (A), 
or co-transfected with Zhx1-HA (B), or with Zhx2-HA (C). Co-
transfection with Zhx3-HA has yield nuclear localization except for two 
cells that showing Zhx1-GFP localizes in the whole cell (D). 
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Figure 5.5 Zhx2 nuclear localization was not altered by Zhx1-
HA, Zhx2-HA or Zhx3-HA. HEK-293 cells were shown nuclear 
Zhx2-GFP localization when it transfected alone (A), or co-
transfected with Zhx1-HA (B), or Zhx2-HA (C), or with Zhx3-HA 
(D). 
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Figure 5.6 Zhx3-GFP whole cell localization was being dramatically 
altered by Zhx2-HA co-transfection in HEK-293 cells. Zhx3-GFP was 
observed to be localized in the entire cell when transfected into HEK-293 
cells alone (A), or co-transfected with Zhx1-HA (B), or Zhx3-HA (D). 
Curiously, co-transfection with Zhx2-HA has altered Zhx3 localization 
to be strictly localized into the nuclei (C). 
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Figure 5.7 3 Dimensional structure prediction of mouse full length 
Zhx1, Zhx2 and Zhx3 proteins. The sequences were inserted in I-
TASSER online server to predict 3 D structure of Zhx1, Zhx2 and Zhx3. 
Zhx1 and Zhx3 have 2 Zinc finger (ZFs) on the N-terminal and 5 HD on 
the C-terminal side (A) and (C). Zhx2 tertiary structure has 2 ZFs on the 
N-terminal and 4 HDs on the C-terminal (B). ZF1 is red, ZF2 is raspberry, 
Homeodomain (HD) 1 is blue, HD2 is light blue, HD3 is purple blue, 
HD4 is magenta and HD5 is white. 
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Figure 5.8 Simulation of the predicted Zhx1, Zhx2 and Zhx3 homodimer. Zhx1 
(green, molecule A) via ZF1, ZF2, HD4 and HD5 can homodimerize with other 
Zhx1 molecule (yellow, molecule B) that participate in the binding via HD1 and 
HD2. ZF1 of Zh2 (green, molecule A) has been anticipated to bind HD1 of Zh2 
(yellow, molecule B) and vis versa (B). ZF1 (red), ZF2 (raspberry), HD2 and HD3 
of Zhx3 molecule (green) has been predicted to bind ZF1 (red), ZF2 (raspberry), 
HD2 and HD3 of the second Zhx3 molecule (yellow) to form a homodimer (C). 
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Figure 5.9 Simulation of the predicted mouse Zhx1, Zhx2 and Zhx3 
heterodimer.  ZF1, ZF2 and HD3 of Zhx1 (yellow) has been predicted 
to bind Zn1 and Zn2 of Zhx2 (green), while HD2 of Zhx1 can bind HD4 
of Zhx2 (A). Zhx1 (yellow) was been predicted to bind Zhx3 (green) 
through ZF1, ZF2, HD1, HD2, HD3 and HD4. While Zhx3 participate in 
the binding via ZF1, ZF2, HD1, HD2 and HD3 (B). Zhx2 (green) has 
been proposed to form a heterodimer with Zhx3 (yellow) via HD1, HD2 
and HD4, while Zhx3 participate in the binding via HD1, HD3 and HD4 
(C). 
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Chapter 6 
Conclusion and future direction 
The hepatic role of Zhx2 has been well documented; however, little was known 
concerning Zhx2 regulation of target genes in non-hepatic tissues. My dissertation has 
ignited a greater interest in further exploring the poorly understood role of Zhx2 in non-
hepatic tissues. My data reported in Chapter 3 suggest that Zhx2 functions as either a potent 
transcriptional activator or repressor of several genes with diverse functions including lipid 
homeostasis, cancer, behavior and a possible correlation with sexually dimorphic gene 
expression. My dissertation was the first in utilizing the Zhx2ko mice in addressing Zhx2 
functions in both hepatic and the non-hepatic tissues. 
The Spear lab, along with collaborators, previously demonstrated that Zhx2 
negatively regulates AFP, H19 [43], Gpc3 [42] and Lpl  and positively regulates Elovl3 
[48]. Additionally, in HCC, nuclear localization of Zhx2 proteins correlates inversely with 
high-grade cancer and has the potency to reduce liver cancer proliferation [65]. Taken 
together, these data provide clinical evidence that Zhx2 may be novel drug target in liver 
cancer which may increase survival. 
Chapter 3 of this dissertation was the first documentation using RT-qPCR that Zhx2 
is expressed ubiquitously, although Zhx2 mRNA levels vary between different organs. I 
discovered that Zhx2 negatively regulates Mup genes in SG in both males and females and 
LG in males (I did not examine female LG), including Mup1, MupU, Mup18, Mup24 and 
Mup25. I will test M MupU in the females SG as it has shown significant reduction by 
Zhx2 in the males. Building upon these observation, it is plausible to examine Mup gene 
expression in female lacrimal glands. Further studies should focus on elucidating the 
mechanism by which Zhx2 controls Mup downregulation in SG and LG.  Although Mup 
genes are not present in human, these data raise the possibility that Zhx2 could be required 
for salivary glands function in mice. Since Zhx2 and Mup expression in the liver increase 
after birth, it would be interesting to examine their expression in the SG and LG starting at 
late embryonic days to p60. It would also be interesting to perfuse the SG to separate it into 
3 regions (parotid, submandibular and sublingual) and then investigate Zhx2 and Mup 
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expression in these regions.  Immunohistochemical staining of the SG to investigate Zhx2 
and Mup localization could also be performed. Since previous studies reported that MupII 
(an old term of liver Mup) the mainly expressed liver Mup has been detected in mice 
mammary glands [97], I hypothesize that mammary gland Mup genes expression will likely 
either be inversely or positively correlated with the Zhx2 deletion. To test this hypothesis, 
one would utilize RT-qPCR to analyze mammary glands Mup expression in Zhx2ko and 
Zhx2wt mice. Moreover, I documented that the Zhx2 deletion did not alter Zhx1 and Zhx3 
levels in the SG.  
I also demonstrated possible clinical relevance of Zhx2 in regards to human disease 
as I detected a significant positive and a trend of negative correlation in the mouse liver 
between Mat1a and Shp, respectively, with Zhx2 (discussed in Chapter 3). Therefore, 
deletion of Zhx2 in mice is likely to disrupt lipid homeostasis, which would influence the 
likelihood of cardiovascular disease. Future directions along these lines should focus on 
elucidating the role of Zhx2 role in CVD. We also hypothesize that Zhx2ko mice could have 
low plasma methionine level similar to Mat1a knockout mice [33]. To test this hypothesis, 
we can analyze methionine levels in the plasma of Zhx2ko and Zhx2wt mice. We can also 
feed mice a high fat diet since we predict that they will get fatty liver similarly to what has 
been observed in Mat1a knockout mice [33]. I predict that Zhx2ko mice, at 8 months of age, 
will exhibit spontaneous macrovesicular non-alcoholic steatosis since this result has been 
seen in Mat1a knockout mice due to elevated liver Cyp2E1 [37].  Indeed, Cyp2E1 might 
be a future target of Zhx2 and may to be elevated in the liver of Zhx2ko mice. Likewise, 
Cyp4A10 and Cyp4A14 are predicted to be downregulated in Zhx2ko mice as they have 
been decreased in Mat1a knock out mice [37]. Since Mat1a knockout mice have enlarged 
liver as compared to the wild type mice [33], and my data documented that Zhx2ko mice 
have lower level of Mat1a expression, we will monitor liver to body ratio of the Zhx2ko 
mice and compare them to the Zhx2wt mice. Since Mat1a is required for VLDL assembly 
and normal plasma lipid levels [36], I propose that Zhx2ko mice could exhibit altered VLDL 
composition. To investigate this, blood VLDL from Zhx2ko and Zhx2wt mice will be 
monitored.  The ratio of the lipid in both cohorts could also be compared. 
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Finally, the molecular switch in gene expression between Mat1a and Mat2a in the 
liver has led me to predict that Mat2a is a prospective negative Zhx2 target, as it resembles 
AFP in being expressed in the fetal liver, switch off after birth and reactivated in liver 
regeneration and HCC [39]. Moreover, Mat2a is expressed in the kidney [39] varies 
between day night [149]; therefore, studies could investigate Mat2a in the liver and kidney 
of Zhx2ko and compare them to Zhx2wt mice at the day and night.  
The fact that decreased testosterone levels decrease Mup gene expression [96] led 
me to hypothesize that testosterone could be downregulated in the Zhx2ko mice, but not 
severely as they have not shown feminine characteristics. 
CD36 fatty acid translocase and PPARγ are positively correlated with Zhx2 in 
Zhx2Δhep mice [Creasy, 2015], and Zhx2 is a potential lipid regulator.  Therefore, I suggest 
testing the expression of CD36 and PPARγ in Zhx2ko and Zhx2wt mice. Additionally, 
Cyp2D6 is a possible negatively-regulated candidate of Zhx2 as it inversely correlates with 
Shp levels [140]. The Shp partner neuronal PAS domain 2 (Npas2) that play a role in lipid 
homeostasis since it regulates lipid oscillation could also be studied. Furthermore, orphan 
receptors ROR and REV-erb correlate with Shp [139], so their levels should also be tested 
in Zhx2ko mice. 
 We could also investigate whether there is liver necrosis in Zhx2ko mice via testing 
GPT, GOT serum levels, in addition to analyzing c-jun and c-fos expression in the liver 
since these markers are altered in the liver after H19 elevation and Shp downregulation 
[136]. Moreover, I suggest testing Smad as target of Zhx2 since its expression correlates 
with H19.  Since H19 is expressed after birth in the skeletal muscle [31], I will test Zhx2 
regulation of Smad in this tissue, as I believe that skeletal muscle is a good future organ to 
study Zhx2 regulation of genes.  
Studies of kidneys demonstrated a trend towards a positive correlation between 
Zhx2 and Stat5b in the female but not male kidney as compared to Zhx2ko mice. These data 
may reach significance with increased mice numbers. Taken together with our previously 
reported data demonstrating a positive correlation of Zhx2 to both of Stat5a and Stat5b in 
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the liver of Zhx2Δhep mice [Creasy Thesis, 2015], and with the independent investigator 
reports documented that both of Stat form regulate growth hormone [146], these data 
suggest that Zhx2 could be associated with kidney developmental delay disorders. Future 
direction for this study should focus on elucidating the mechanism by which Zhx2 
promotes Stat5b expression in the kidney. Moreover, to determine whether Zhx2 is 
participating in normal kidney function, we could examine podocyte protein-tyrosine 
phosphatase (GLEPP1) as its expression has been reported to be decreased when there is 
defect in the kidney function [159]. It has been reported that castrated mice decrease kidney 
Cyp2a4 concordant with increase Cyp2a4 in the liver [148]. It would be of interest for our 
study to examine the influence of Zhx2 status on the reciprocal regulation of Cyp2a4 in 
castrated Zhx2Δhep mice. 
As mentioned in Chapter 3, I reported a trend toward a positive correlation between 
Zhx2 and Shp within the male brain.  Therefore, I suggest testing Shp in female brain 
samples. Moreover, we observed a trend, in females only, towards a positive correlation 
between Zhx2 and Mup18. Since BALB/cJ mice exhibit a small brain size [81], I propose 
that Zhx2ko mice could have small size brain as will be compared to Zhx2wt mice. To test 
this hypothesis, we could monitor brain to body weight ratio in the mice cohort (project in 
progress). Moreover, I hypothesize that Zhx2 could correlate with ephrin-B in the brain 
since they have been reported to bind each other [76], and miR-4277 since it has been 
hypothesized to be associated with Zhx2 in Parkinson disease. To validate this assumption, 
we will quantify their expression in the Zhx2ko and Zhx2wt mice. 
Although I did not detect any correlation between Zhx2 and the Zhx2 target gene 
expression in the small intestine, I suggest testing Mcpt-2 in the small intestine of Zhx2ko 
and Zhx2wt mice infected or not infected with helminths, since Mcpt-2 has been detected 
in BALB/cJ mice after parasite stimulation [144]. 
Since we hypothesized that Zhx2 could bind to its targets promoters to reduce or 
enhance expression via its two ZF and four HD, I propose that Zhx2 activate Mat1a, Shp, 
Stat5b, repress H19, repress/or activate Mup1, Mup18 via direct binding to their promoters. 
We could conduct several assays to test this hypothesis. First, we could amplify and purify 
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H19, Mat1a, Shp, Stat5b, Mup1, MupU, Mup18 promoter regions from BL/6 mice 
genomic DNA and clone them into pGEM-TEasy vector (promega) and verify their 
identity by sequencing. Fragments could then be excised and subcloned into the luciferase 
vector pGL4.14. Transient transfections could then be performed in HEK-293 or AML-12 
cells with Zhx2 and the luciferase reporter plasmids. After cotransfection the cells with 
Zhx2 and the constructs, we would anticipate the luciferase level will be either elevated for 
Mat1a and Stat5b constructs or decreased for Shp, H19, Mup1 and Mup18. If the predicted 
results are obtained, serial promoter deletion constructs could be used to identify a Zhx2 
consensus binding site.  Targets that show potential Zhx2 binding will further be confirmed 
utilizing chromatin Immunoprecipitation (ChIP). Alternative methods could also be used 
to analyze Zhx2 function, including the yeast-2-hybrid system. 
 If experiments reveal Zhx2 does not directly bind control regions of target genes, 
an alternative hypothesis is that Zhx2 could regulates targets via posttranslational events. 
In support of this hypothesis previously, our lab has generated AFP-promoter construct 
since AFP is the well-known target of Zhx2. Although, BALB/cJ mice, possess mutated 
Zhx2, have 10-20 fold higher AFP than BALB/c mice (see Chapter 1 for details), AFP 
promoter-Luc has shown only 2-fold difference after cell line transfection. This puzzling 
data suggest a post-translational events. Data generated by Dr.Peterson lab (Turcios, L and 
Peterson, M unpublished data) have detected antisense-AFP further supporting this 
hypothesis. 
BALB/cJ are more susceptible to fibrosis than other mice strains. QTL analysis in 
a cross between BALB/cJ mice and A/J mice, a fibrosis-resistant mouse strain, has mapped 
the fibrotic gene (later named Hfib1) to chromosome 15. Interestingly, Zhx2 resides in this 
area. Therefore, we anticipate that treating Zhx2ko mice with CCl4 will induce more fibrosis 
damage than Zhx2wt mice.  
In Chapter 4, I reported that male Zhx2ko mice are more vulnerable to die than 
female Zhx2ko mice early after birth. Since our lab previously documented that Zhx2 
regulation of Cyp2a4 was more sever in the livers of males than females, it is conceivable 
that Zhx2 could promote survival via regulation of genes that are required for male survival 
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more than female survival. As mentioned in Chapter 4, I hypothesized that the small size 
of Zhx2ko mice could lead to low growth hormone levels due to downregulation of Ghrhr 
gene expression, as it documented to be mutated in little mice [160]. Several experiment 
could be performed to test this hypothesis. First, we could measure the expression of Ghrhr 
as well as testing insulin like growth factor (Igf1), growth hormone (GH), prolactin (prl), 
and thyroid stimulating hormone (TSH). Second, we could examine the gene that is 
mutated in Amber dwarf mice [160]. These markers could help define the molecular 
differences in small Zhx2ko mice.   It would also be interesting to test whether Zhx2 could 
contribute to insulin homeostasis and diabetes.  Glucose and insulin levels could be 
analyzed in Zhx2wt and Zhx2ko mice with high glucose fluid.  Additionally, I propose that 
ethylmorphine demethylase (EMDase) could be a prospect negative target of Zhx2 in the 
Zhx2ko males’ livers. This enzyme has been reported to be higher in Balb/cJ male mice 
than females. This sexually biased enzyme has not been seen in CRL:CD1 mice [161]. 
Since the mice that are dying are males (see Chapter 4 for details), EMDase can have a 
potential toxic to new born mice. Worth notable, EMDase is active in the guinea pig inner 
zones of the adrenal cortex [162]. 
Our collaborator data previously demonstrated that translocation of Zhx2 from the 
nucleus to the cytoplasm in HCC patients were associated with poor prognosis. In Chapter 
5, my in vitro analysis identified nuclear localization of Zhx1 and Zhx2 and cytoplasmic 
localization of Zhx3. In addition, I discovered a possible direct binding between Zhx2 and 
Zhx3 that shifted Zhx3 to the nucleus. I hypothesize that Zhx2-HA binds Zhx3-GFP and 
shifted it to the nucleus. To test this, fixed cells can be stained with Anti-HA antibodies. 
Alternatively, I might use Zhx2 and Zhx3 proteins fused to different fluorescent protein to 
visualize the binding and use confocal microscopy. Immunoprecipitation followed by 
western blot could also be used to reveal direct binding. If experiments reveal that proteins 
do not bind each other, an alternative proposal is that Zhx proteins can influence each other 
localization via third factors. This hypothesis could be tested using mass spectrometry to 
discover the direct binding proteins. The same proposed experiments can be done to reveal 
whether Zhx1 or Zhx2 can form heterodimers.  I should note that this is the first report to 
use computational analysis to study Zhx genes. My bioinformatics search identified several 
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binding domains that could be involved in forming homodimers and heterodimers. Further 
insight could be obtained using site-directed mutagenesis, followed by transient 
transfection, then, co-immunoprecipitation of the predicted binding protein. Future 
directions for this study will focus on elucidating the molecular mechanisms by which Zhx 
proteins can influence each other’s localization and how these alterations may be relevant 
to human disease. It would also be of interest to examine the localization of Zhx proteins 
in different tissues using immunohistochemistry techniques. 
In summary, a better understanding of Zhx protein location, function, and 
biological activity may be employed as unique therapeutic targets. In the future, I highly 
recommend investigating the molecular functions of Zhx proteins and their proposed 
targets since they might shed the light for broader role of Zhx genes could be relevant to 
human disease and develop efficacious and direct drugs application help to heal several 
types of cancers and diseases. 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Minen Al-Kafajy 2016 
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APPENDEX 
LIST OF ABBREVIATION  
Abbreviation Description 
a.a Amino acid 
AFP αfetoprotein  
ANOVA Analysis of variance  
ASD 
Apo 
Autism Spectrum Disorder 
Apolipoprotein  
B Brain 
CCl4 Carbon tetrachloride  
CFA Freunds’ adjuvants  
CNV Copy number variation  
Cyp2a4 Steroid 15α-hydroxylase testosterone  
DRG Dorsal root ganglia  
Elovl3 Elongation of very long chain fatty acids like 3  
FBS Fetal bovine serum  
FSH Follicle stimulating hormone  
GFP Green fluorescent protein 
GH Growth hormone  
HD  Homeodomain 
HDL High density lipoproteins  
HEK293 Human embryonic kidney cells  
HeLa Human cervical cancer  
Hep3B Human hepatoma  
HFD High fat diet 
Hnf4a Hepatocytes nuclear factor 4a  
HNF-4α and γ Hepatic nuclear factors  
Igf1 Insulin like growth factor 
K Kidney 
Kb Kilobase 
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KOMP Knockout mouse project  
L Liver 
LG Lacrimal gland 
LH Luteinizing hormone  
Lpl Lipoprotein lipase  
LXRα Liver X receptor  
Mat1a Methionine adenosyltransferase 1a  
MOE Main olfactory epithelium  
NAFLD Non-alcoholic fatty liver disease 
ND Normal diet 
NES Nuclear export signal 
NLS Nuclear localization signal  
Nr0b2 Neuronal PAS domain 2  
ob/ob Obese mice  
PPARα, β, γ1, 
and γ2 
Peroxisome proliferator activated receptors α, β, γ1, and γ2 
prl Prolactin  
RXRα Retinoid X receptor  
SG Salivary gland 
SI Small intestine 
SREBP-1c Sterol regulatory element binding protein-1c  
Stat5 signal transducer and activator of transcription 5  
TSH Thyroid stimulating hormone  
VLDL Very low density lipoprotein  
VNO Vomeronasal organ  
WT 
Zhx 
Wilms tumor  
Zinc finger protein 
Zhx1 Zinc finger and homeoboxes 1 
Zhx2 Zinc finger and homeoboxes 2 
Zhx2het  Heterozygous Zhx2 mice 
Zhx2ko Whole body Knock out Zhx2mice 
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Zhx2wt Wild type Zhx2 mice 
Zhx2Δhep Hepatocytes specific Zhx2 knock out mice 
ZHX3 Zinc finger and homeoboxes 3 
Zn  Zinc finger domain 
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C-terminal GFP tagged of mouse Zhx1 protein. GFP sequence (lower case nucleotides at 
the C-terminal side).  
   
mdykddddKASRRKSTTPCMVLASEQDPDLELISDLDEGPPILTPVENAK 
AESVSSDEEVHGSVDSDNQQNKKVEGGYECKYCTFQTPDLNMFTFHVDSE 
HPNVVLNSSYVCVECNFLTKRYDALSEHNLKYHPGEENFKLTMVKRNNQT 
IFEQTINDLTFDGSFVKEENTEQGESIDVSSSGISISKTPIMKMMKNKVE 
NKRITVHHNSAEGTSEEKENGVKASQEENAESVSSSALESNTSTSTINRV 
HPSPASTVVTPTAVLPGLAQVITAVSAQQNSNLLPKVLIPVNSIPTYNAA 
LDNNPLLLNTYNKFPYPTMSEITVLSAQAKYTEEQIKIWFSAQRLKHGVS 
WTPEEVEEARRKQFNGTVHTVPQTITVIPTHISTGSNGLPSILQTCQIVG 
QPGLVLTQVAGTNTLPVTAPIALTVAGVPNQTNVQKSQVPAAQPATDTKP 
ATAAVPSSPSVRPEAALVNPDSFGIRAKKTKEQLAELKVSYLKNQFPHDS 
EIIRLMKITGLTKGEIKKWFSDTRYNQRNSKSNQCLHLNNDSSATIIIDS 
SDETPEPPAAAASQQKQSWNPFPDFAPQKFKEKTAEQLRALQASFLNSSV 
LTDEEVNRLRAQTKLTRREIDAWFTEKNKTKALKDEKIEVDESNVGSSKE 
EPGESSPGDETVAPKSGGTGKICKKTPEQLHMLKSAFVRTQWPSAEEYDK 
LAEESGLARTDIVSWFGDTRYAWKNGNLKWYYYYQSSNSSSLNGLSSLRR 
RGRGRPKGRGRGRPRGRPRGGKRMNTWDRVPSLIKFKTGTAILKDYYLKH 
KFLNEQDLDELVNRSHMGYEQVREWFAERQRRSELGIELFEENEEEDEVV 
DDQEEDEEETDDSDTWEPPRHVKRKLSKSDDgsvskgeelftgvvpilve 
ldgdvnghkfsvsgegegdatygkltlkficttgklpvpwptlvttltyg 
vqcfsrypdhmkqhdffksampegyvqertiffkddgnyktraevkfegd 
tlvnrielkgidfkedgnilghkleynynshnvyimadkqkngikvnfki 
rhniedgsvqladhyqqntpigdgpvllpdnhylstqsalskdpnekrdh 
mvllefvtaagitlgmdelyk 
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FLAG-Zhx1-GFP plasmid: Mouse Zhx1 was subcloned from pcDNA 
to FLAG-CMV-GFP vector using the appropriate restriction sites 
(Plasmid image: Snap Gene viewer). 
112 
 
C-terminal Flag tagged of mouse Zhx2 protein and the GFP sequence (lower case 
nucleotides at the C-terminal side).  
mdykddddKASKRKSTTPCMVRTSQVLEQDMLEEADRAKDKGAGMPQSDV 
TKDSWAAEPEHSSKETEVVEVKSMGENLSKKLQGGYECKYCPYSTQNLNE 
FTEHVDMQHPNVILNPLYVCAECNFTTKKYDSLSDHNSKFHPGETNFKLK 
LIKRNNQTVLEQSIEATNHVVPITASGPGSSDNDPGVSVGKTPMTKTGKL 
KADAKKVPKKPDEAAPENHMEGTARLVTDTAEILARLGSVELLQDSLGHV 
MPSVQLPPNINLVPKVPVPLNTTKYNSALDTNATMINSFNKFPYPTQAEL 
SWLTAASKHPEEHIRIWFATQRLKHGISWSPEEVEEARKKMFNGTIQSVP 
PTITVLPAQLTPTKVSQPILQTALPCQILGQPSLVLTQVTSGSTTVSCSP 
ITLAVAGVTNHGQKRPLVTPQAAPEPKRPHIAQVPEPPPKVANTPLTPAS 
DRKKTKLQIAHLKASFLQSQFPDDAEVYRLIEVTGLARSEIKKWFSDHRY 
RCQRGIVHITSESLAKDQMAITGTRHGRTYHVYPDFAPQKFKEKSQGQLK 
TLEDSFLKSSFPTQAEVERLRVETKLSRREIDSWFSERRKLRDSMEQAVL 
DSMGSGKKGSDAVAPNGALSRLDQLSGAQLAGSLPSPSSAIVQNQEQVHL 
LRSTFARTQWPTPQEYDQLAAKTGLVRTEIVRWFKENRCLLKTGTLSWLE 
QYQRHHMSDDRGRDAVSRKVAKQVAESPKNGSEAAHQYAKDPKALSEEDS 
EKLVPRMKVGGDPTKDCLAGKPSEATSDRSEGSRDGQGSEENEESGIVDF 
VEVTVGEEDAISEKWGSWSRRVAEGTVERADSDSDSTPAEAGQAgsvskg 
eelftgvvpilveldgdvnghkfsvsgegegdatygkltlkficttgklp 
vpwptlvttltygvqcfsrypdhmkqhdffksampegyvqertiffkddg 
nyktraevkfegdtlvnrielkgidfkedgnilghkleynynshnvyima 
dkqkngikvnfkirhniedgsvqladhyqqntpigdgpvllpdnhylstq 
salskdpnekrdhmvllefvtaagitlgmdelyk 
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FLAG-Zhx2-GFP plasmid: Mouse Zhx2 was subcloned from pcDNA 
to FLAG-CMV-GFP vector using the appropriate restriction sites 
(Plasmid image: Snap Gene viewer). 
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C-terminal Flag tagged of mouse Zhx3 protein and the GFP sequence (lower case 
nucleotides at the C-terminal side).  
mdykddddKASKRKSTTPCMIPVKTVVLPGASTEPQPVESLPEGPQQDLP 
SEAPDASSEAAPNPSSTDGSALANGHRSTLDGYVYCCKECEFRSQDVTHF 
IGHMNSEHTDFNKDPTFVCTGCSFLAKNPEGLSLHNAKCHSGEASFLWNV 
TKPDNHVVVEQSVPDSASSSVLAGESTTEGTEIIITKTPIMKIMKGKAEA 
KKIHMLKENAPNQPGSEALPKPLAGEREVKEGDHTFINGAAPGSQASAKS 
TKPPPAANGPLIGTVPVLPAGIAQFLSLQQQPPVHAQHHTHQPLPTSKTL 
PKVMIPLSSIPTYNAAMDSNSFLKNSFHKFPYPTKAELCYLTVVTKYPEE 
QLKIWFTAQRLKQGISWSPEEIEDARKKMFNTVIQSVPQPTITVLNTPLV 
ASAGNVQHLIQATLPGHAVGQPEGTAGGLLVTQPLMANGLQASSSSLPLT 
TASVPKPTVAPINTVCSNSASAVKVVNAAQSLLTACPSITSQAFLDANIY 
KNKKSHEQLSALKGSFCRNQFPGQSEVEHLTKVTGLSTREVRKWFSDRRY 
HCRNLKGSRAMMPGEHGSVLIDSVPEVPFPLASKVPEVTCIPTATSLVSH 
PATKRQSWHQTPDFTPTKYKERAPEQLRVLENSFAQNPLPPEEELDRLRS 
ETKMTRREIDGWFSERRKKVNTEETKKADGHMPKEEEEGAEQEGRDEELA 
NELRVPGENGSPEMFLSHALAERKVSPIKINLKNLRVTEASGKSEFPGMG 
VCEPEEDGLNKLVEQPPSKVSYKKTAQQRHLLRQLFVQTQWPSNQDYDSI 
MAQTGLPRPEVVRWFGDSRYALKNGQLKWYEDYKRGNFPPGLLVIAPGNR 
ELLQDYYMTHKMLCEEDLQTLCDKTQMSAQQVKQWFAEKMGEETRAVADI 
SSEDQGPRNGEPVAVHKVLGDAYSELSENSESWEPSAPEASSEPFDTSSP 
QSGRQLEADgsvskgeelftgvvpilveldgdvnghkfsvsgegegdaty 
gkltlkficttgklpvpwptlvttltygvqcfsrypdhmkqhdffksamp 
egyvqertiffkddgnyktraevkfegdtlvnrielkgidfkedgnilgh 
kleynynshnvyimadkqkngikvnfkirhniedgsvqladhyqqntpig 
dgpvllpdnhylstqsalskdpnekrdhmvllefvtaagitlgmdelyk 
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FLAG-Zhx3-GFP plasmid: Mouse Zhx3 was subcloned from pcDNA 
to FLAG-CMV-GFP vector using the appropriate restriction sites 
(Plasmid image: Snap Gene viewer). 
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Homology within mouse Zhx1, Zhx2 and Zhx3 proteins showing the two Zinc finger (ZF) highlighted yellow, 
and four (for Zhx2) or five (Zhx1 and Zhx3) homeodomains (HDs) highlighted blue. 
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